






Title of Dissertation: 
 
 STRUCTURAL AND FUNCTIONAL STUDIES OF 
TAILSPIKE PROTEINS FROM ESCHERICHIA 
COLI O157:H7 PHAGE CBA120 
   
  Julia Y. Greenfield, Doctor of Philosophy, 2019. 
 
   
Dissertation Directed by: 
 
 Dr. Osnat Herzberg, Professor, 
Department of Chemistry and Biochemistry 
 
 
Bacteriophage CBA120, a member of the Ackermannviridae family, was isolated, 
sequenced, shown to selectively infect the food pathogen E. coli O157:H7. The CBA120 
genome encodes four separate tailspike proteins (TSPs), TSP1-4 corresponding to ORFs 
210 through 213. TSPs bind and degrade or modify the lipopolysaccharide (LPS) on the 
bacterial cell surface as part of the adsorption apparatus of tailed bacteriophages. Electron 
microscopy revealed that phage CBA120 possesses a long contractible tail with distinct 
star-like structures attached to the baseplate of the tail.  
 Sequence analysis of the four CBA120 TSPs suggests two distinct classes; one class 
comprising TSP1 and TSP3 corresponds to two-domain structures. The second class 
comprising TSP2 and TSP4 have longer amino acid sequences and contain additional N-
terminal regions responsible for the assembly of the TSP star-like complex. Crystal 
structure of TSP1 at 1.8 Å resolution and TSP3 at 1.85 Å resolution revealed two-domain 
 
 
homotrimers displaying conserved N-terminal head domain structures and C-terminal 
receptor binding domains with an overall β-helical fold. Sequence analysis of the assembly 
regions of TSP2 and TSP4 reveal remote homology to gp10 of phage T4, which is involved 
in the assembly of the phage baseplate. The crystal structure of TSP2 reveals the head 
domain and receptor binding domain, but the N-terminal assembly region is structurally 
disordered. In contrast, the assembly region of TSP4 has been purified without the head 
and receptor domain; pull-down experiments showed that this region binds TSP1. 
Bacterial halo assays of TSPs 1-3 revealed that all three proteins produced circles of 
clearing corresponding to polysaccharide depolymerase activity. Site-directed mutagenesis 
coupled with the halo assay confirmed the identity of TSP3’s catalytic residues as Asp383 
and Asp426, which, based on the structure, suggests that the enzyme employs an acid/base 
mechanism to degrade lipopolysaccharide.  The structure-based putative active site of 
TSP2 suggests that the catalytic machinery comprises Asp506 and Asp571. It was also 
shown that TSP2, but not TSP1 or TSP3, diminishes CBA120’s ability to infect E. coli 
O157:H7. Thus, TSP2 is the phage specificity determinant that binds to the 
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Chapter 1: Introduction 
 
As more viral genomes are sequenced, and DNA sequencing costs decrease, we can unlock 
the many unique and specialized mechanisms bacteriophages use in their fight against 
bacteria.  The use of phages as antimicrobial agents has been practiced as early as 1920; 
however, the rise of antibiotics has made the development of phage and phage product 
therapies a low priority1. More recently, the growing prevalence of drug-resistant bacteria 
and the rapid growth of the number of phage genome sequences have revived interest in 
using these organisms as a viable and mostly untapped resource for new biocontrol and 
therapeutic agents. This dissertation focuses on structural and biochemical studies of 
bacteriophage CBA120, a virus that infects pathogenic Escherichia coli O157:H7 and a 
cause of widespread gastrointestinal disease. Understanding the mechanism it utilizes to 
invade the pathogen is the first necessary step for developing the phage or phage 
components as antibacterial agents. 
1.1  E. coli O157:H7 
 
Escherichia coli is a rod-shaped, Gram-negative bacterium that can inhabit the intestines 
of people and animals. Most strains are harmless; however, some are pathogenic, including 
E. coli O157:H7. First recognized in 1982, E. coli O157:H7 is one of the most common 
Shiga toxin-producing E. coli (STEC) pathogens identified in North America2. Infection 
by Enterohemorrhagic E. coli (EHEC) such as O157:H7 can cause hemorrhagic colitis, 
characterized by bloody diarrhea and extreme abdominal discomfort. In a small percentage 





blood cell damage is accompanied by acute kidney failure2, 3. Antibiotics are not usually 
prescribed to treat E. coli O157:H7 infection because the rapid killing of the bacteria can 
cause Shiga toxin to be released from dead cells and worsen symptoms, and increase the 
risk of developing hemolytic-uremic syndrome. Therefore, there is no standard treatment 
for EHEC infections that target the bacteria directly; however, intravenous fluids can be 
given to combat dehydration caused by diarrhea associated with the infection4. For the 
small population of patients who develop hemolytic-uremic syndrome, treatment to reduce 
the symptoms of the illness include dialysis for those experiencing renal failure and blood 
transfusions for the hemolytic anemia caused by the destruction of red blood cells4, 5. 
Despite the medical consensus of avoiding antibiotics to treat E. coli O175:H7 infection, 
resistance to antibiotics has been described5.  The Center for Disease Control reports 3,704 
confirmed cases of E. coli O157:H7 annually; however, many cases are undiagnosed or 
misdiagnosed, suggesting the actual number of instances to be closer to 63,0006.   
 
In addition to the physical suffering of those infected with the pathogenic microbe, there is 
also an associated economic burden.  The cost related to contaminated food includes 
hospitalization, loss of wages, legal fees, recall expenses and, loss of profits for the food 
industry. The United States Department of Agriculture (USDA) monitors contaminated 
food recalls; in 2017, recalls caused by STEC pathogens reached 144,000 lbs7. This number 
is lower than the 10 million pounds of food recalled during 20138, and food companies still 
endured a heavy financial burden as the result of a product recall.  For example, I.M. 
Healthy company has filed for bankruptcy since its 2017 recall of SoyNut Butter that was 





Americans suffered from a foodborne illness in 2011 and Dr. Robert Scharff, of Ohio State 
University’s Food Innovation Center, estimates that the total cost of foodborne illness in 
the United States reaches $55 billion annually10.  
 
Despite the precautions taken by the food industry, E. coli O157:H7 remains a persistent 
food pathogen.  Ungulates such as cattle and deer can serve as a reservoir for E.coli 
O157:H7 and be asymptomatic5, 11. Infected animals shed the pathogen in their feces, which 
can contaminate recreational and drinking water used by humans5. During the slaughtering 
process, bacteria from infected animals can be incorporated into meat intended for human 
consumption. Moreover, bacterial contamination can spread to food processing equipment 
and surfaces increasing the risk of cross-contamination with other food products. 
Thoroughly cooking the infected meat can kill the bacteria and reduce the chance of 
infection; however, many outbreaks with minimally processed food products such as apple 
cider, salad, and sprouts have been recorded12. Produce contamination is primarily 
attributed to cross-contamination from infected meats at restaurants or facilities that 
process both meat products and minimally processed foods12. Unlike meat products, 
consumption of minimally processed food products is more concerning because consumers 
do not necessarily cook these products before eating, and it takes <100 bacteria to cause 
illness5. 
 
E. coli O157:H7, as many other bacteria, have defense mechanisms for survival in hostile 





heterogeneous matrix called a biofilm. Bacterial biofilm is formed by secreting 
polysaccharides, proteins, and DNA, which comprise the extracellular polymeric 
substances (EPS)13. Biofilms can grow on a variety of surfaces from natural products such 
as vegetables and industrial materials14. The biofilm structure provides a local environment 
where a subset of the bacterial community persists in a metabolically inactive state while 
being protected from desiccation and other environmental hazards. Biofilms also provide 
a physical barrier from bacteriophages and antimicrobial agents13, 15. These metabolically 
inactive bacteria are not susceptible to many antimicrobial agents, but recover their activity 
when the biofilm structure is compromised15. The released bacteria can then colonize a 
new area. The cyclic growth of biofilm formation can cause chronic infection inside a host 
organism or persistent contamination on external surfaces.   
 
Gram-negative bacteria contain external lipopolysaccharides (LPS) that extend from the 
cell surface. Also known as endotoxins, because they can produce hemorrhagic shock when 
released from dead cells, these molecules consist of three components: lipid A, core 
oligosaccharide, and O-antigen see Figure 1.1. The lipid A contains phosphates, 
glucosamine, and fatty acid chains that anchor the LPS to the bacterial membrane. Lipid A 
is connected to the core, which can be further divided into two, the inner core and the outer 
core.  The inner core is bound to lipid A by several keto-deoxyoctulosonate (KDO) and 
heptose moieties and is conserved over bacterial genus. In contrast, the outer core contains 
more variability within a genus. There are five known outer core types associated with E. 
coli including the R3 core type, which is found in many virulent isolates including 





carbohydrate polymer that extends out from the bacterial surface. O-antigens vary across 
different strains of E. coli. The genes encoding enzymes that synthesize these structures 
are located on the O-antigen gene cluster. E. coli O157 gene cluster includes 12 genes 
involved in the production of N-acetyl-D-perosamine, L-fucose, D-glucose, and N-acetyl-
D-galactose, the components of the O157: H7 antigen; see Figure 1.117, 18.    
 
 
Figure 1.1 Lipopolysaccharide composition. 
(A)The hydrophobic lipid A anchors the LPS in the cell membrane. Inner and outer core 
make up the common core structure of the LPS, and O-antigen is a repeating unit of four 
sugars attached to the core (figure adapted from Hughes et. al19). (B) The O-antigen 
structure of E. coli O157 includes the following four sugars; D-4-N-acetylperosamine 
(D-Per4NAc), L-fucose (L-Fuc), D-glucose (D-Glc), and D-2-N-acetylglucosamine (D-
Glc2NAc,). (Figure adapted from Samuel et al. 200418). 
 
1.2 Bacteriophages  
Caudovirales, the order of double-stranded tailed DNA bacteriophages, represent a diverse 
group of viruses with an estimated ten million species20. Tailed phages have one of the 





(capsid) containing their dsDNA genomes, and their tail appendage. The Caudovirales 
order is further divided into families based on their tail morphology; the Podoviridae, 
which have short non-contractile tails; the Siphoviridae, which have long non-contractile 
tails; and the Myoviridae, which have long contractile tails illustrated in Figure 1.213. The 
tail machinery is responsible for host recognition before adsorption and transport of the 
DNA to the host during infection. Caudovirales have a baseplate connected to the end of 
the tail to which tailspikes or tail fibers are attached.  The tailspikes (TSPs), the focus of 
this investigation, are responsible for binding, selective host recognition, and in contrast to 
tail fibers, tailspikes can also possess enzymatic activity that degrades the LPS20. Various 
TSPs have been studied, revealing several characteristics: their lack of amino acid sequence 
homology, their conserved three-dimensional fold, and the affinity for lipopolysaccharide 
(LPS) of their specific host organism13. In addition to their LPS selectivity, some TSPs also 
hydrolytically cleave the polysaccharides of the LPS, allowing the phage unhindered 






Figure 1.2  Illustration of tailed bacteriophages. 
Myoviridae, Siphovirdae, and Podoviridae are the three families of tailed 
bacteriophages. At the distal end of the tail is the adsorption apparatus consisting of a 
baseplate, tail fibers/tailspikes, and a tail needle to inject their dsDNA. Figure adapted 
from Casjens et al. 200521.  
 
 
Host infection by the bacteriophage is a three-step process: 1) the phage binds reversibly 
to the polysaccharide secondary receptor such as the LPS, 2) the phage uses its 
depolymerase activity to degrade the polysaccharide of the LPS, and 3) the phage 
recognizes and binds irreversibly to the primary receptors on the cell surface and invades 
the bacterial cell13, 22.The long contractile tails of the Myoviridae are essential for their 
efficiency during the infection process. These tails consist of many proteins including long 
tail fibers, which can interact with the primary receptors on the bacterial cell surface; the 
tail needle required for the phage to inject its DNA; and the TSPs, which recognize the 





specific bacterial targets and degrade the LPS makes them drug candidates for bacterial 
control.  Specifically, a phage or a phage component that selectively targeted E. coli 
O157:H7 offers opportunities to develop biologics to treat or prevent E.coli O157:H7 
contamination in food products, thereby preventing illness.  
The Viunalikevirus genus belongs to the Myoviridae family; they are distinguished by 
several traits including genomes of similar size (approximately 150,000+ base pairs), T4-
like regulation of late transcription, the use of a modified form of uracil rather than 
thymine, and the use of tailspikes rather than tail fibers for host recognition24. Electron 
microscopy of members of this genus uncovered an unusual tail structure that differs from 
the long spinally tail fibers of the T4-like myovirus. Instead, Viunalikevirus members have 
an elaborate organization of branched star-like projections coupled with bulbous prongs 
protruding from the base plate, illustrated in Figure 1.3. Most members of the genus encode 
four TSPs, unlike other phages, which encode only a single TSP24. Because of their 
multiple TSPs, it has been suggested that perhaps these phages can infect a broader range 
of bacteria25. Indeed, infection of multiple bacteria species has now been identified with 






Figure 1.3 Schematic illustration of Viunalikevirus Genus Phage. 
Cartoon adapted from “A suggested new bacteriophage genus: Viunalikevirus’’ by 
Adriaenssens et al.25. The tail apparatus shows the prongs at the bottom of the baseplate. 
Also connected to the baseplate are branched projections. 
 
Escherichia phage vB_EcoM_CBA120 (CBA120), a member of the Viunalikevirus genus, 
has a 157,000 base pair genome and four TSPs24, denoted here TSP1-4.  CBA120 was 
isolated from a cattle feedlot and was shown to infect the enterohemorrhagic E. coli 
O157:H73, 26. Bacteriophage CBA120 has specificity towards multiple E. coli O157: H7 
stereotypes, infecting 13 of the 17 O157 strains tested, but only 1 out of 77 non-O157:H7 
strains tested from the E. coli Reference Collection27. CBA120’s specificity towards E. coli 
O157:H7 is of particular interest because it may be developed as a potential new bio-
indicator and biocontrol agent.  
 
CBA120 phage has morphology consistent with the reported morphology of other 
Viunalikevirus genus phages (see Figure 1.3). CBA120’s icosahedral capsid, which 





consists of 24 transverse striations connecting the tail to the base plate. The adsorption 
apparatus is anchored to the baseplate at the distal end of the tail; branched star-like 
structures emanate from the sides of the baseplate, and bulbs prongs protrude from the 
bottom of base plate; see Figure 1.3. To date, this genus includes seven sequenced 
members: Salmonella phages ViI, SFP10 and ΦSH19; Escherichia phages CBA120 and 
PhaxI; Shigella phage phiSboM-AG3; and Dickeya phage LIMEstone1. Their shared 
myovirus morphology, with comparable capsid sizes and tail dimensions, and genome 
organization are considered distinguishing features as detailed, in Table 1.1. They appear 
to have conserved regulatory sequences, a horizontally acquired tRNA set, and the 
probable substitution of an alternate base for thymine in the DNA. A close examination of 
the tailspike encoding region of the genome revealed four distinct tailspike proteins, and it 
was proposed that they assemble into an arrangement that comprises the star-like structures 
of the tails visible on electron micrographs. The star-like structures that fan out from the 
baseplate of CBA120 appear morphologically different from the long spinally tail fibers 
present in T4 phages, and it remains unknown whether it corresponds to the four tailspike 
encoded in CBA120’s genome. These morphological properties set the Viunalikevirus 
genus apart from the recently ratified subfamily Tevenvirinae, although a significant 
































91.4 113.8x14 152,427 201 76% / 155 28 
Escherichia 
phage CBA120  




phage PhaxI  
85-86 115x15 156628 209 95.1% / 194 29 
Salmonella 
phage Sfp10  
*86 *109x18 157950 201 93.1% / 190 25 
Salmonella 
phage ΦSh19  
83 110x14 157,785 166 77.9%/ 159 30 
Salmonella 
phage ViI 
88-90 110x18 157,061 208 88.5% / 184 24, 31 
Shigella phage 
Ag3 
83 110x14 158,006 216 85.3 / 174 32 
*Dimensions calibrated by Adriaenssens et al. 201224. 
# Genome similarity determined by CoreGene33 against the genome of CBA120. 
 
Overall, the seven identified phages in Viunalikevirus genus have similar genomes 
supporting the classification of a distinct genus in 2012 by Kutter et al.24. The 
CoreGenes3.533 webserver was used to compare the genomes of the Viunalikevirus 
members against CBA120 to identify sequence homology and overall similarity amongst 
the phages. Viunalikevirus members share a significant number of homologs; at least 150 
homologous genes were identified in ΦSh19, while PhaxI, with 194 genes, showed the 
largest number of homologs to CBA120. According to this analysis, all annotated 
Viunalikevirus genomes demonstrated better than 75% similarity when compared to 
CBA120, phage ViI (88.5% similarity), PhaxI (95%), SFP10 (93%), AG3 (85%), 





BLASTn search of Viunalikevirus members and depicted the results using the BLAST 
Image Ring Generator (BRIG) tool34. As seen in Figure 1.4, the region around 110kBP-
130kbp, where the genes for TSPs are encoded, show significant gaps in similarity. An 
expansion of this region is depicted in Figure 1.5. 
 
The BLASTn comparison shows four gaps for ΦSh19, ViI, and AG3 corresponding to the 
genes encoding TSP1-4. However, their TSP genes are significantly different from 
 
 
Figure 1.4 BLASTn Genome Comparison of Viunalikevirus members against 
Phage CBA120. 
The innermost rings show the GC content (black) and GC Skew (purple/green). The third 
innermost ring shows the CBA120 genome in red. The remaining rings show the 
remaining members of the Viunalikevirus genus: LIMEstone1, PhaxI, Sfp10, phiSH19, 
ViI, and AG3. The coloring scheme is indicated on the right. The area with the most 
dissimilarities occurs in the region encoding the CBA120 TSP1-4 (orf 210-213). This 





CBA120, hence the gaps. PhaxI and SFP10 only have two gaps in this region of their 
genome when compared to CBA120. The gaps can be explained by the fact that PhaxI and 
SFP10 encode two tailspikes that are homologs to CBA120’s (PhaxI encodes for TSP2 and 
TSP4 homologs, and SFP10 encodes for TSP1 and TSP2 homologs). LIMEstone1 only 
encodes for 3 TSPs, and they are all significantly dissimilar from CBA120 to cause gaps 
to be displayed in this area. In addition, two of LIMEstone1’s tailspikes are missing the 
catalytic domain. 
 
Figure 1.5 Expansion of the tailspike encoding regions of Viunalikevirus genus. 
 
The gaps correlate to TSP1-4, specifically the receptor binding domain of each gene. 
Preceding each area of low identity, the conserved regions represent the head domains of 





diversity because this region of the tailspike determines host specificity; Viunalikevirus 
members have a variety of hosts and therefore variability in their host receptor proteins. 
1.3 The Family of Ackermannviridae 
 
During the writing of this thesis, the taxonomy regarding Viunalikevirus genus has been 
changed. Since several key references refer to the original genus classification, and I will 
continue to use it for this thesis. The current classification information was proposed and 
accepted by the International Committee on Taxonomy of Viruses (ICTV) after a 
“reassessment of the genus and phages related to its members”35. The result requires an 
expansion of the order of Caudovirales to include a new family, Ackermannviridae35-37, 
see Figure 1.6. Under the Ackermannviridae family, there are two subfamilies Aglimvirinae 
and Cvivirinae. Escherichia phage CBA120 is the type species of the newly formed genus 
Cba120virus which is under the Cvivirinae subfamily. Members of the genus Cba120virus 
are characterized as having genomes that average  158.1 kbp in length and  44.5 mol % 
G+C content35. Most members of this genus encode approximately 201 proteins; however, 
there a few exceptions including Salmonella phage PhiSH19 and Salmonella phage 3835.  
Every member of the genus Cba120virus  has a DNA sequence identity of 86% or better 
to CBA12035. Along with the creation of Cba120virus genus three other genera were 
created;  the Ag3virus, Limestonevirus, and the Vi1virus. Each of these new genera contains 
a former member of the Viunalikevirus genus as type species: Shigella phage phiSboM-








Figure 1.6 Taxonomy of the Ackermannviridae family.  
The order of Caudovirales contains a new family of bacteriophage, the Ackermannviridae. 
Escherichia phage CBA120 serves as the genus type representative of the Cba120virus 
genus which contains four members from the former Viunalikevirus genus.  
Table 1.2 Members of the Cba120virus genus 
Phage Name GenBank 
accession 
No. 
RefSeq No. Genome 
length (kb) 







JN593240 NC_016570 157.3 44.5 100 204 
Salmonella phage 
SFP10 








NC_019452 156.6 44.5 93 209 
Salmonella phage 
Det7 # 
KP797973 NC_027119 157.5 44.6 86 210 
Salmonella phage 
PhiSH19 
JN126049 NC_019530 157.8 44.7 86 166 
Salmonella phage 38 
#  
KR296692 NC_029042 156.8 44.6 265*** 265*** 
Salmonella phage 
vB_SalM_PM10 # * 
KX438380 NC_031128 158.1 44.6 209 209 
Salmonella phage 
vB_SalM_SJ3 
KJ174318 NC_024122 162.9 44.4 210 210 
 *** sequence contains numerous errors; # new species, § type species in the genus 












Table 1.3 Former Members of Viunalikevirus genus  
Phage Name GenBank 
accession 
No. 
RefSeq No. Genome 
length (kb) 








HE600015 NC_019925 152.4 49.3 201 Aglimvirinae Limestonevirus 
Shigella phage 
phiSboM-AG3§ 
FJ373894 NC_013693 158.0 50.4 216 Aglimvirinae Ag3virus  
Salmonella phage 
Vi01§ 




§ genus type species 
Table adapted from Kropinski et al. 201735 
  
 
1.4 Tailspike Proteins (TSPs) 
 
In order for phage adsorption to take place, the phage receptor binding proteins must 
interact with bacterial receptors. TSPs serve as the receptor binding proteins that facilitate 
the initial reversible contact between the phage and the bacterial cell. TSPs form stable 
trimeric proteins, with each protomer containing two main domains see Figure 1.7 28. The 
N-terminal domain includes the head domain that attaches the tailspike to the baseplate of 
the virus particle or other tailspikes. The head domain is divided into two subdomains, D1 
and D2, following the notation used to describe TSP1 from phage CBA12038. The C-
terminal domain, also known as the receptor binding domain, is further divided into two 
subdomains, a large β-helix domain (designated thereafter the D3 subdomain following the 
notation of TSP1 from phage CBA120), followed by a smaller C-terminal domain, which 
varies in fold among tailspikes and has been designated as the D4 subdomain, see Figure 
1.8. The β-helix domain serves two functions: recognizing and cleaving the host bacteria’s 
receptor24, 39. The activity that degrades the polysaccharide receptor is often, but not 





bacteriophage. Although the receptor binding domains of known TSP structures exhibit the 
same overall fold, they lack significant amino acid sequence homology. The C-terminal 
subdomain (D4) has proven to be essential for tailspike trimerization of Phage P22’s TSP40, 
but this role has not been confirmed in other TSPs.  
 
Figure 1.7 Tailspike trimer of CBA120's TSP1. 
Full-length TSP1 is depicted here as a highly integrated homotrimer. Two distinct 
domains connected by alpha-helix linker are observed38. PDB 4OJ5. 
 
Instead of glycosidase activity, some TSPs merely modify the LPS or act on others 
substrates altogether. For example, TSPs of bacteriophages G7C, K1F or P22 have diverse 
enzymatic activity and substrates. Phage G7C’s TSP deacetylates LPS41, K1F TSP is an 
endosialidase that cleaves the polysialic acid of its host's capsule42, and P22 is a hydrolase 
acting on a sugar branching from the repeating subunit of the Salmonella O-antigen43. The 
C-terminal domain of the 3-D structures of G7C and K1F TSPs do not adopt a β-helix fold, 
however, P22’s tailspike does. The diversity of TSP sequences makes it impossible to 






Figure 1.8 Structures of TSP receptor binding domain monomers sharing a β-
helix catalytic domain. 
Following the notation used to describe the phage CBA120 TSP1, the catalytic 
domain will be designated the D3 subdomains (green). The D4 subdomains (cyan) 
fold varies between TSPs. Turns and loops are colored gray. Bound sugars are shown 
as space-filling spheres. Figure adapted from Chen et al. 201438. 
 
 
Table 1.4 Features of β-helical TSPs with determined crystal structures. 






4OJ5 82/trimer Unknown 
P22 1TYW 72/ trimer endorhamnosidase 
SF6 2VBE 67/trimer endorhamnosidase 
HK620 2VJI 77/trimer endo-N-
acetylglucosaminidase 










1.5 Salmonella Phage P22 
 
The TSP of Salmonella phage P22 has been studied most extensively, and the knowledge 
derived from these studies has provided the context for understanding other TSPs. Phage 
P22 TSP’s active site serves as both receptor binding site for host recognition and a receptor 
endoglycosidase.  It may seem as nonproductive for the receptor binding protein to also 
destroy the receptor. However, the slow activity of P22’s TSP, one cleavage a minute at 10 
° C, is fine-tuned for the initial host recognition, and the slow enzymatic activity enables 
the phage to take advantage of the binding-affinity without destroying the receptor too 
quickly. Although not demonstrated, it was suggested that the endoglycosidase activity 
might also play a role in releasing phage progeny from the lysed bacterial cell debris, 
freeing them to infect other cells. Such receptor-destroying activity is seen in influenza 
type A neuraminidase, which is responsible for releasing the virus from bacterial surface 
sugars. It is important to note that unlike TSPs, the influenza type A neuraminidase is not 
essential for host recognition, a function carried by a hemagglutinin43 .   
 
The structure of bacteriophage P22, as determined by cryogenic electron microscopy 
(Cryo-EM), is shown in Figure 1.9, identifying the location of the TSP. The crystal 
structure of the P22 TSP was determined in 1996 by Steinbacher et al.43. The Cryo-EM 
structure of P22 shows six homotrimers are present on the Phage P22 tail structure44, 45. 





lyase, an enzyme with glycosidase activity46.  Thus, the presence of the β-helix motif in 
CBA120 TSP1, as well as in the TSPs of P22, HK620, Sf6, and Φ29, suggests, although it 
does not prove, a glycosidase activity.  Consistent with the fold of its receptor binding 
domain, the P22 TSP acts on the O-antigen of several related salmonella serotypes, 
including serotype A, B, and D1 which share a common trisaccharide repeat43.  
 
Figure 1.9 Cryo-EM reconstruction of Podoviridae phage P22. 
(A) A cross section of the Phage P22 structure shows the capsid and the tail apparatus. 
The tail is made up of several essential proteins including TSP, as labeled. (B) The tail 
hub proteins and needle make up the bulk of the tail apparatus. Two distinct domains are 
visible on the TSP, the head domain and the receptor-binding domain. The crystal 
structure of P22 tailspike fits well in this space. Figure adapted from Chang et al. 200644. 
 
The saccharide binding site of P22 tailspike is located in a shallow depression on the 
surface of the β-helical domain and flanked by extended loops on either side. The active 
site of P22 TSP contains three carboxylic acid residues, E359, D392 and D395, all located 





to 30,000 fold reduction in enzymatic activity43. The binding site cleft can accommodate 
eight saccharide units or two repeats of the O-antigen, as seen in Figure 1.1047. 
 
Figure 1.10 Phage P22 saccharide binding Site (PDB:3TH0) 
(A) Cartoon representation of a full length P22 tailspike monomer with bound S. 
Paratyphi A octasaccharide (gray) (B) A surface representation of P22 TSP trimer with 
one monomer in cartoon representation showing The S. Paratyphi A octasaccharide 
(yellow spheres). (C) The active site of P22 has three potentially catalytic residues 
E359, D392, and D395; interacting with the octasaccharide substrate.  Figure adapted 
from Andres et al. 201348.  
 
1.6 Phage CBA120 TSPs 
 
Since TSPs and tail fibers are known to convey host specificity, the roles of CBA120’s 
four TSPs are intriguing. As mentioned above, it was suggested that the multiple TSPs 
expand the range of hosts the phage infects, but this has not been proven24. The amino acid 





between the four TSPs corresponds to the head domains with 39-70% amino acid sequence 
identity over 155 residues. TSP2 also shows sequence homology to the maturation-
adhesion protein of  Phage ViI tailspike protein 171c. Based on their domain structure, 
TSP1 and TSP3 resemble TSPs from the Podoviridae family24. However, TSP2 and TSP4 
contain additional domains N-terminally to the head domain. It is tempting to speculate 
that these domains are involved in the assembly of the branched projections seen in electron 






Chapter 2: Electron Microscopy of CBA120 
 
2.1  Introduction  
 
The morphology of Viunalikevirus genus along with genomic sequencing provided 
significant support for the genus classification Adriaenssens et al.24.  The distinctive 
structural feature on the tail of Viunalikevirus genus members along with genomes that 
encode for multiple TSPs suggests that these phages have an unusual arrangement of TSPs. 
To investigate the positions of the TSPs on the virus tail, Transmission Electron 
Microscopy (TEM) was used. The TEM images of Vil, LIMEstone1, PhaxI, SFP10, 
ΦSH19, Ag3, and CBA120 shown in Figure 2.124, 25, 27, 29, 30, 32 demonstrate tail 
arrangements similar to the illustration in Figure 1.3. Capsid shape, contractile tails, and 
the “star-like” projections that extend from the bottom of the base plate have been reported 
in all the TEM images. The star-like projections are seen in many of the images; however, 
there is some variation amongst the members of the genus. Most notably TEM images of 
Dickeya phage LIMEstone1 lacks the elaborate branched structure present on the other 
phages.  This difference can be attributed to the fact that LIMEstone1 phage encodes for 
only one complete tailspike (orf158), and truncated versions of two other tailspikes (orf159 
and 160), which have sequence homology to the N-terminal domains of TSP2 and TSP4 
respectively24. Because the published images of the CBA120 phage were not clear, (Kutter 
et al. 201127) I obtained new images from phages I cultured, showing the branched 






Figure 2.1 Electron micrographs of Viunalikevirus genus phages 
(A)  Salmonella phage Vil demonstrates a complex tail structure with many branched 
projections24. (B) Dickeya phage LIMEstone1 phage lacks the elaborate branched tail 
structure but contains the prong-like projections24. Other members of the genus have a 
structure consistent with Salmonella phage ViI, including (C) E. coli Phage PhaxI29, (D)  
Salmonella phage SFP1025, (E) Salmonella phage ΦSH1930, (F) Shigella Phage Ag332, 
(G, H) E.coli phage  CBA12027. 
 
2.2 Material and Methods 
 
CBA120 bacteriophage, obtained from Dr. Elizabeth Kutter at Evergreen State College in 
Olympia, W.A., was used to inoculate E. coli O157:H7 ATCC700728 and the culture was 
grown in Luria-Bertani broth for four hours, centrifuged at 2500 rpm for 15 min at 4 °C. 
The E. coli was pelleted, and the supernatant was filtered with a 2µm filter to remove any 
bacterial cells. The CBA120 present in the supernatant was then concentrated using a 50 





0.5% uranyl acetate were mixed in a microcentrifuge tube. The mixture spotted on a 
carbon-covered copper 200 mesh grid (Ted Pella, Inc.), and examined on a Joel 2100 
Transmission Electron Microscope (TEM) at 200kv with a CCD camera. 
2.3 Results 
  
The electron micrographs of CBA120 are consistent with other Viunalikevirus genus 
members except for LIMEstone1 phage, which only encodes for one complete tailspike 
(Figure 2.2). The capsid diameter is consistent with 90 nm as reported by Kutter et al.27. 
The tail apparatus depicts a collar (Figure 2.2 arrow A) and a segmented tail sheath of 
approximately 100 nm. The baseplate is obscured by the elaborate star-like projections 
extending away from the tail (Figure 2.2 arrow B). Also visible are the stubby projections 




Figure 2.2 TEM image of CBA120. 
(Left) E. coli Phage CBA120 phage from the current work. (Right ) Enlargement of  
CBA120’s tail showing both the “stubby” prongs and the star-like structures around the 





2.4 The Proposed Analogy Between G7C and CBA120 Tailspike 
Assemblies  
 
While Salmonella Phage P22 has revealed a lot about the structure of a tailspike, another 
member of the Podoviridae family has provided insight that allows us to speculate about 
the arrangement and interactions of receptor binding proteins in phages that encode 
multiple TSPs. This phage is N4-like phage vB_EcoP_G7C (phage G7C), which infects E. 
coli 4s, a bacteria that infects the equine intestinal tracts49. The genome of phage G7C has 
71,759 base pairs and 78 open reading frames, much smaller than the CBA120 genome, 
which contains 150,000 base pairs and 213 orf24, 49. The electron micrograph of phage G7C 
(Figure 2.3) shows that the tail includes tailspikes extending from the base in a branched 
arrangement reminiscent of the one seen in Viunalikevirus genus. Also seen in the figure 








Figure 2.3 EM image of phage G7C. 
Star-like structures reminiscent of the ones seen in the Viunalikevirus genus are 
indicated by arrow A. Thin projections extending from the collar are indicated by arrow 
B. Figure adapted from Kulikov et al. 2012 49 . 
 
Phage G7C has two distinct receptor binding proteins, tailspikes gp63.1 and gp66. The 
former is a tailspike that deacetylates E. coli 4s’s LPS. Gp63.1 forms an elongated 
homotrimer of 851 amino acids per monomer, with each monomer containing a head 
domain and a receptor binding domain41, 49. The N-terminal head domains of gp63.1 have 
been shown to be essential in the assembly of the branched tailspike structure in G7C41.  
Consisting of the first 155 amino acids, the head domain of gp63.1 exhibits 74%, 60% and 
63% sequence identity to the head domains of  TSP1, TSP3, and TSP4 head domains, 
respectively, see Figure 2.4. Adopting the same overall fold, gp63.1’s head domain has a 
0.5Å (RMSD) of α-carbon atoms to TSP1’s head domain. Gp63.1 receptor binding domain 
has demonstrated deacetylation activity against E. coli 4s LPS.  Interestingly gp63.1 does 
not cleave the LPS of E. coli 4s; instead, it deacetylates a carbohydrate moiety on the O-
antigen41. The receptor binding domain of gp63.1 does not show any homology to the 








Figure 2.4 Sequence alignment of the head domain of phage G7C’s gp63.1 vs. 
CBA120’s TSP1, TSP3, and TSP4.  
Multiple sequence alignment was produced by T-coffee alignment program 51.  
 
The similarity of the head domains of G7C’s gp63.1 and TSP1 suggest that they may have 
originated from a common ancestor. However, the divergent receptor binding domains 
indicate that the “spare parts” theory may apply here, where protein domains assemble 
through horizontal gene transfer and recombination 41. Accordingly, gp63.1 does not adopt 
the glycosidase β-helix fold; instead, it contains a SGNH hydrolase-type esterase domain 
responsible for the deacetylation activity41. 
Gp66, the second and larger tailspike of phage G7C comprises 1,063 amino acids. The first 





responsible for binding the tailspike to the virus particle. The second and third domains, 
comprising residues 138-294 are responsible for binding to gp63.141. Domains four and 
five span residues 295-460 and exhibit 37% identity to the head domains of gp63.1 and, 
32%, 61%, and 39% to the CBA120’s TSP1, TSP2, TSP4 head domains, respectively 
(Figure 2.5). Gp66’s C-terminal domain is predicted to be a β-helical receptor binding 
domain, but its structure has not been elucidated. Figure 2.6 illustrates the proposed 
structure of G7C tailspike assembly and the interaction between gp63.1and gp6641. The 
model is based on pull-down experiments of gp66 domain deletion mutants41. 
  
 
Figure 2.5 Sequence alignment of the head domain phage G7C’s gp66 and 
CBA120’s TSP1, TSP2, and TSP4.  








Figure 2.6 A Diagram of the proposed G7C’s tailspike assembly structure 
Tailspikes and gp66 associate with the rest of the virus particle via its particle binding 
domain (red).  Tailspike gp63.1’s N-terminal binding domain interacts with domain 2 
of gp66 (Figure adapted from Prokhorov et al. 201741). 
 
  
By analogy to gp66 of phage G7C, the large N-terminal insertions preceding the head 
domains of CBA120’s TSP4 and perhaps TSP2 may mediate the assembling of the 
branched tailspike structures observed in the EM images (~330 and 170 additional amino 
acids for TSP4 and TSP2, respectively (Table 2.1)). According to this model, the smaller 
TSP1 and TSP3 (~600-800 amino acids) would be analogous to gp63.1 because they 
contain only head and catalytic domains (Table 2.2). The CBA120 tailspike interactions 





Table 2.1 Proposed domains of  Assembly TSPs 
Phage Host Protein Residue ranges 









(with neck and 
C-ter. domain) 
G7C41 E. coli 4s gp66 1-138 139-294 295-467 467-1063 
CBA120 E. coli 
O157:H7 
TSP2 - 1-167 168-245 246-921 
TSP4 1-81 82-329 330-480 481-1043 
 
 
Table 2.2 Proposed domains of Branching TSPs 
Phage  Host  Protein  Residue ranges 
   Head domain  Receptor binding domain (with neck 
and C-ter. domain) 
G7C41 E. coli 4s Gp63.1 1-155 156-851 
CBA120 E. coli 
O157:H7 
TSP1 1-155 156-770 
  TSP3 1-154 155-627 
 
 
The head domain of TSP4 begins at approximately amino acid 330, as inferred by the 74% 
sequence identity with the head domain of TSP1. By analogy to gp66, the preceding 
residues (1-329) may be responsible for interactions with other TSPs that assemble into the 
branched structures, and for attachment to the phage baseplate. For gp66, residues 1-138 
have been proposed to be responsible for attachment to the phage particle and residues 139-
294 for anchoring gp63.141. BLAST sequence alignment of the TSP4 residues 1-335 with 
residues 1-294 of the gp66 reveals homology between ~70 residues of TSP4 (264-335) and 





208 (38% identity and e-value of 2x10-11) and the second spans residues 221-293 (37% 
identity of and e-value of 3x10-11). These gp66 domains were reported to be related to D2 
and D3 domains of gp10 from phage T4, and required for binding of gp63.1 to gp66 41. 
The homology of residues 264-335 of TSP4 to the two related gp66 domain supports the 
hypothesis that TSP4 residues preceding the head domain are involved in assembling other 
TSPs to form the branched structure seen in the EM images. In contrast, there is no 
sequence homology between TSP4 and the first 140 amino acids of gp66 that were 
proposed to be involved in the attachment of the tailspike to the main viral particle.  
 
In addition, Hidden Markov model analysis using the program HHpred52 reveals sequence 
relationship of TSP4 to phage T4’s gp10 and gp9 that are components of the phage T4 
baseplate and are involved in multiple protein-protein interactions53-56. The probability of 
sequence relationship between TSP4 residues 82-329 and gp10 residues 49-383 is 98% and 
the e-value is 2.2x10-5, spanning a region that comprises the first three gp10 domains 
(designated D1-3). For gp9 residues 67-221, the alignment probability of TSP4 residues 
82-227 is 97% with e-value of 1.5x10-4, spanning residues that comprise two domains of 
gp9 analogous to D1 and D2 of gp10. Each of these T4 domains adopts a β-sandwich fold, 
forms homotrimers, and engages in complex interactions with other protein domains. As 
CBA120 contains three more TSPs in addition to TSP4, it is tempting to speculate that the 
TSP4 residues 82-329 contain three β-sandwich domains, which are required to mediate 
interactions with the three partner TSPs. Thus perhaps the first 82 residues are involved in 






Amino acid residues 1-167 of TSP2 remain structurally undefined, as they are disordered 
in the crystal structure (section 4.5). The head domain (residues 168-245) adopts the same 
fold as subdomain D1 of TSP1 and TSP3 but lacks the D2 subdomain. Interestingly, 
BLAST alignment reveals sequence homology between residues 100-154 of TSP2, and 
residues 147-201 of G7C’s gp66, corresponding to the predicted gp66 assembly domain. 
The sequence identity between TSP2 and G7c’s gp66 is 32%, and the e-value is 1x10-3. 
Also, HHpred reveals the similarity between the residues 16 – 161 of TSP2 and residues 
160 – 389 of T4 gp10, spanning domains D2 and D3, with HHpred probability score of 
96% but with rather high e-value of 0.034. Therefore, TSP2 N-terminal domain may also 






Figure 2.7 Proposed assembly of CBA120's TSPs. 
(A) Proposed assembly of the star-like projections on CBA120 depict TSP4 (black) as 
the major assembly tailspike and TSP1(red), TSP2(green), and TSP3(blue) interacting 
with its assembly domain(s) (AD). (B) The tailspike apparatus is attached to the rest of 
the virus with the particle binding domain (PBD) of TSP4. TSP1 and TSP3 interact with 
the ADs via their head domains while TSP2 interacts with TSP4 via its AD. We 
hypothesized that the AD of TSP2 might facilitate the interaction of TSP3 (which will 
be discussed later).  The C-terminal receptor binding domains (RBD) remain available 
to interaction with O-antigens. 
 
Figure 2.7 depicts a proposed model for the arrangement of CBA120’s TSPs based on 
sequence analysis and comparison of G7C’s tailspikes and T4’s gp9 and gp10. Future 
experiments to validate the model will include structural studies of TSP complexes and 






Chapter 3: Sequence Analysis of CBA120 Tailspikes  
3.1 Introduction 
In nature, proteins that exhibit sequence identity of ~30% tend to share the same overall 
three-dimensional structure. The sequences of phage TSPs are often unrelated, yet the 
catalytic domains of most form β-helix trimers. However, when there is no significant level 
of identity, the β-helix structures are quite diverse in detail, as evidenced by the inability 
to determine the structure of one TSP by molecular replacement using a search model of 
another TSP lacking significant amino acid sequence homology. The rapidly increasing 
number of phages sequenced raises an interesting question: To what extent new structures 
of TSPs resemble the structures of other known TSPs and how they differ. Sequencing of 
the bacteriophages from the Viunalikevirus genus has demonstrated that all members have 
substantial gene sequence similarities over their entire genome and encode similar proteins. 
The one area of significant divergence occurs in the region of the genome that encodes 
sequences assigned as TSPs24. 
  
3.2 TSP1 and TSP3  
 
A Basic Local Alignment Search Tool (BLAST) protein search of the non-redundant 
database, against TSP1, retrieved four phage proteins with better than 93% sequence 
identity and 97% coverage. These include an unnamed protein product of the 
Viunalikevirus genus member Salmonella phage SFP10 (YP_004895331.1) and three non-
Viunalikevirus genus members including a tail fiber from Salmonella phage S8 





fiber protein from Escherichia phage FEC14 (ATW66762.1). The homologous regions for 
the proteins mentioned above covered a majority (>90 %) of TSP1. However, there are 
other proteins with significant sequence similarity over distinctly smaller coverage range 
that all demonstrated an e-value of 5x10-19 or better. These areas of similarity can be 
divided into two groups with respect to the crystal structure of TSP138, one group showing 
sequence homology to the head domain (approximately 155 residues) and the other to the 
receptor binding domain (approximately 615 residues)38. 
 
Head domains homologous to that of TSP1 are present in numerous phage proteins 
including the tailspike protein of Salmonella phage vB_SalM_SJ3 (YP_009030454.1) 
which has 96% identity to TSP1 over the first 163 amino acids. In all, a BLAST search 
against the entire TSP1 amino acid sequence yielded about 85% of the top 100 hits with 
sequence identities to the head domain, including the TSP3 and TSP4 head domains of 
phage CBA120, which share ~70% sequence identity with TSP1 head domain, 
respectively. This level of similarity indicates that these domains share the same fold. The 
top 100 BLAST hits also contained 10% sequences that showed sequence identity to the 
receptor binding domain of TSP1, including Salmonella phage S115’s tailspike 
(AXC40512.1), which has 93% sequence identity to TSP1 covering the first 480 residues 
of Salmonella phage S115’s TSP.  When the BLAST search is performed with the TSP3 
sequence, the results are similar. About 84% of the top 100 hits exhibit sequence identity 
only to the N-terminal domain of TSP3, including the Salmonella phage 38 protein 
annotated as tail fiber (YP_009220801.1), which has 95% identity to the first 170 N-





TSP3 receptor binding domain including E. coli bifunctional tail protein 
[WP_001544389.1], which shows 66% identity.  
3.3 TSP2 and TSP4 
 
A BLAST search reveals that the entire TSP2 protein sequence, including the N-terminal 
domain of unknown function,  is 99% identical to that of several proteins from other 
bacteriophages: Proteins annotated as tail fibers of Salmonella phage vB_SalM_SJ3 
(YP_009030453.1), Salmonella phage BSP101 (ARM69919.1), Escherichia phage EP75 
(AVZ45056.1), Salmonella phage S8 (ARB06441.1), Salmonella phage S117 
(AXC40876.1), Escherichia phage EP75 (AVZ45056.1), Escherichia phage PhaxI 
(YP_007002808.1), along with  the tailspike 2 of Salmonella phage S115 (AXC40514.1), 
hypothetical proteins from Escherichia phage FEC14 (ATW66764.1), Salmonella phage 
GG32 (YP_009283775.1), and unnamed protein product of Salmonella phage SFP10 
(YP_004895332.1). Although some of these proteins are annotated as tail fiber proteins, 
the enzymatic activity of TSPs from CBA120 described later suggests that these 
annotations might need revision.  
 
Additionally, Salmonella ViI phage’s tailspike Vi01_171c, a maturation-adhesion protein, 
and TSP2 share 91% sequence identity over the first 247 amino acids. This sequence 
identity suggests that the two proteins have a similar 3D structure for the domains they 
share. One can hypothesize that the N-terminal domain of TSP2 is important in the protein-
protein interactions that assemble the multiple tailspike “star-like projections” seen at the 





do not contain the N-terminal domain shared by ViI and TSP2; however, ViI is the only 
one of the Salmonella Vi phage type that encodes for three tailspike proteins. 
 
Conversely, there is no homology between the two proteins beyond the first 240 residues, 
where Vi01_171c’s tailspike encodes for a conserved acetyl esterase domain present in all 
the maturation-adhesion proteins of Salmonella Phage Vi types 1- 7. The tailspike for ViI 
phage, Vi01_171c is a maturation-adhesion protein, that has an acetyl esterase domain that 
modifies the acetyl groups on the exopolysaccharide capsule specifically, α-1,4-linked N-
acetyl galactosaminuronate57. Maturation-adhesion proteins with acetylesterase activity 
disrupt the EPS capsule of Salmonella by destabilizing the carbohydrate structure and 
reducing hydrogen binding. 
 
Figure 3.1 Alignment of the N-terminal domains of TSP2 and Salmonella phage 
maturation-adhesion protein. 
The first 240 amino acids exhibit 91% sequence identity; thus they should adopt a similar 







TSP4 contains a longer N-terminal domain than TSP2, 335 amino acids long. Salmonella 
S8 phage (ARB06439) encodes a full-length TSP4 homolog with 99% sequence identity. 
Other Salmonella phages (SP1, vB_SalM_PM10, SFP10, GG32, vB_SalM_SJ3, Det7, 
SH19, vB_SalM_SJ2, SFL-SP-029, SFL-SP-063) exhibit 90-98% identity to TSP4 only 
within the N-terminal and head domains, underscoring the diversity of phage sequences 
and perhaps the exchange of genetic material. A goal of this study is to discover whether 
the N-terminal regions of TSP2 or TSP4 play a role in the assembly of the branched 
structures around the base plate. I have begun addressing this by producing the N-terminal 
domain of TSP4 for structural and biophysical characterization.  
 
3.4 The Sequence Diversity Within CBA120 TSPs  
 
 Despite the difference in the TSP-encoding region, some similarities make identifying 
these TSPs easier. The head domain of CBA120’s TSPs, spans 15-25% of the overall 
polypeptide and exhibit sequence identity in this domain. The head domain precedes the 
catalytic domain of the TSPs and consists of approximately 155 amino acids. The crystal 
structure of TSP1 from CBA120 published previously (Chen et. al38) revealed a head 
domain structure unlike any previously published structure. Comparison of the head 
domain sequences of TSP1-4 shows 70% or greater sequence identity between TSP1 and 
TSP3 and TSP4. Whereas the sequence identity between the head domain of TSP1 and 
TSP2 is limited to only one subdomain of the head domain (D1), of which they share 39 
% sequence identity. The sequence identity of the TSP3 and TSP4 head domains to that of 
TSP1 is sufficient to conclude that their overall three-dimensional structures are similar. 





fold of the D1 domain only. The lack of sequence homology between the D2 subdomain 
of TSP1 and TSP2 indicated that TSP2’s head domain is different. In section 4.5 we will 
learn that TSP2 lacks the D2 subdomain completely.  
 
Figure 3.2 Sequence alignment of TSP 1-4 head domains. 
Sequence alignment reveals the area of the most sequence similarity spans the head 
domain. The location of the head domain along the polypeptide chain varies depending 
on whether the TSP is an assembly TSP or a branching TSP.  Multiple sequence 
alignment was produced by T-coffee alignment program 51. 
 
Table 3.1 Characteristics of CBA120 Tailspike proteins 
 orf 210 orf 211 orf 212 orf 213 
Name  TSP1 TSP2 TSP3 TSP4 
Size (amino acid) 770  922 628 1037 
Start of the head domain  
(residue number ) 
1 173 1 345 
% Sequence Identity to 
orf210 head domain 
100 39* 70 72 









Figure 3.3 Domain constructs of CBA120's TSP's 
This figure shows two structural domains for TSP1 and TSP3  and the additional N-










Chapter 4:  Biophysical Characterization and Crystal Structures of 
CBA120 Tailspikes 
 
4.1  Introduction 
 
Chapter 4 describes tailspike stability studies, early investigation of interactions between 
the proteins, and crystallographic studies. I have contributed to the crystallographic studies 
of all four CBA120 TSPs. For TSP1, I obtained the crystals that were used in data 
collection. However, the structure determination was primarily carried out by another 
group member (Chen et al. 2014 38). Although I co-authored the TSP1 paper, this 
dissertation does not describe the work in detail. Included here are the structural studies of 
the remaining TSPs, TSP2, TSP3, and TSP4, performed by myself, acknowledging the 
contributions of others as appropriate. 
 
4.2 Materials and Methods 
 
4.2.1  Cloning, Expression, and purification of TSP2, TSP3, and TSP4 
The nucleic acid sequences of TSP2-4 were codon optimized for expression in E. coli and 
synthesized with a C-terminal 6X-His tag using GeneArt. The genes were sub-cloned into 
a pBAD24 expression vector, and the resulting clones were used to transform Rosetta-
gami™ two- competent cells38. The transformed cells were used to inoculate 2x YT 
medium supplemented with 200 μg/mL ampicillin at 37º C for 4-8 hours until the OD600 
reached 0.8. The temperature was lowered to 18ºC, and the culture was induced with 0.25% 
arabinose overnight. The biomass was collected by centrifugation and resuspended in 1x 





centrifugation at 14,000 rpm for 45 minutes. The resulting supernatant was incubated in 
Ni-NTA agarose for one hour at 4º C after which, the TSP was purified by gravity-flow 
chromatography and dialyzed in Tris-HCl buffer pH 7.5 and concentrated. The expression 
of selenomethionine (SeMet) containing TSP3 followed the same protocol except that the 
cells were grown in SeMet™ medium (Molecular Dimensions Limited) supplemented with 
40 mg/L SeMet. 
4.2.2 Site-directed Mutagenesis 
TSP3 mutants were produced by the Nelson Lab using the QuikChange II Site-Directed 
Mutagenesis Kit (Agilent Technologies). Primers (Error! Reference source not found.) 
were designed to include mutations in the middle of a 30 nucleotide primer with the 
phosphorylated reverse primers complementary to the next 30 nucleotides upstream. The 
resulting PCR products were digested by DpnI to remove the methylated templates, ligated 
and transformed into E. coli DH5ɑ. The mutations were confirmed by nucleotide 
sequencing (Macrogen, USA) before being transformed into E. coli for protein expression. 
4.2.3 Size-exclusion Chromatography 
The multimeric state of CBA120’s TSPs was assessed by analytical size-exclusion 
chromatography. The Superdex 200 column (GE Healthcare) was equilibrated with PBS 
and TSP was applied to the column. The samples were run under isocratic conditions in 
PBS for 1.5 column volumes on an AKTA FPLC system (GE Healthcare). The molecular 
mass of TSPs was estimated from a standard curve generated by linear regression of log 
(molecular mass) vs. retention volume using gel filtration standards (Bio-Rad). 
4.2.4 Protein Stability 
The thermal stability of TSP3 and TSP2 were investigated by the Nelson lab using a 





mM sodium phosphate buffer, pH 7.0, was gradually heated at a rate of 1 °C/min from 20 
°C to 95 °C. The mean residue ellipticity (MRE) of the sample contained in a quartz cuvette 
of 1 mm path length was monitored every 0.5 °C at 218 nm with 5 s signal averaging per 
data point. The data was then smoothed, normalized, and fit with a Boltzmann sigmoidal 
curve using the Pro-Data software (Applied Photophysics). The melting temperature (Tm) 
was determined by calculating the first derivative, which was determined from the 
minimum value of the derivative graph.  
  
TSP3 sensitivity to LDS was assessed by incubating 0.25 mg/mL of TSP3 in lithium 
dodecyl sulfate (LDS) sample buffer (Invitrogen) (0.5% final LSD concentration ) for 10 
mins at room temperature or boiled. The resulting sample was analyzed on a 7% SDS-
PAGE. TSP3 resistance to proteolysis was analyzed using 0.25 mg/mL samples incubated 
at 37 °C for one day with 0.5 mg/mL trypsin (Sigma Aldrich) or chymotrypsin (Sigma 
Aldrich) at a ratio of 1:25 (w/w) protease and TSP3. The protease reaction buffer contained 
20 mM sodium phosphate, pH 7.0, and 1 mM CaCl2. Bovine serum albumin BSA (Sigma 
Aldrich) served as control and was incubated overnight with and without protease. The 
resulting samples were analyzed on 7% SDS-PAGE.  
4.2.5 Pull-down Experiment with TSP4-N and Branching TSPs 
In order to test TSP4-N’s association with TSP1 and TSP3, a pull-down experiment was 
conducted by the Nelson group. His-tagged TSP4-N was equilibrated on a Ni-NTA agarose 
column and washed to remove any unbound protein. Then tag-free TSP1 or TSP3 enriched 
lysate was applied to the column and washed again to remove any unbound tailspike. The 





4.3 Protein Purification and Characterization 
 
4.3.1 Purification of TSPs 
Cloning and purification of TSP2 and TSP3 followed the standard protocol described in 
the Material and Methods section 4.2.1. Several milligrams of full-length TSPs were 
produced and purified using affinity chromatography (see Figure 4.2A-B). However, full-
length TSP4 was not expressed using this expression protocol. Several TSP4 constructs 
were designed for cloning and expressing smaller constructs of TSP4 (Figure 4.1). The 
constructs were designed using the sequence identity between TSP4 and TSP1; and the 
secondary structure prediction by PSIPRED58, 59 as a guide in determining the domain 
boundaries. Of the seven constructs three were cloned (options 1, 3, and 7), and option 1 
expressed sufficient protein for further investigation. Option 1 contains the first 335 
residues of TSP4 and spans the predicted particle binding domain and the assembly domain 
and hereby referred to as TSP4-N. Similar to TSP2 and TSP3, several milligrams of soluble 






Figure 4.1 Constructs of TSP4. 
Seven contracts of TSP4 were designed based on predicted domain boundaries. Option 
1, referred to in this work as TSP4-N, is predicted to contain two domains: the particle 







Figure 4.2 SDA-PAGE gel of TSP2-4 purification. 
SDS-PAGE following the purification of 6X-his C-terminal tagged TSP2-4 after Nickel-
NTA agarose binding and elution using an imidazole step gradient. (A) SDS-PAGE of 
TSP2 purification, Lanes:  flow through (1); protein ladder (2); 50 mM imidazole (3); 50 
mM imidazole (4); 100 mM imidazole (5); 100 mM imidazole (6); 150 mM imidazole 
(7); 150 mM imidazole (8); 200 mM imidazole (9); 200 mM imidazole (10); 250 mM 
imidazole (11); 250 mM imidazole (12). 
(B) SDS-PAGE of TSP3 purification, Lanes:  flow through (1); protein ladder (2), 20 
mM imidazole (3), 20 mM imidazole (4); 50 mM imidazole (5); 50 mM imidazole (6); 
100 mM imidazole (7), 100 mM imidazole (8); 150 mM imidazole (9); 150 mM 
imidazole (10); 200 mM imidazole (11); 200 mM imidazole (12).  
(C) SDS-PAGE of TSP4-N purification, Lanes: Dilute whole cell lysate (1); supernatant 
(2), flow through (3), 20 mM imidazole (4); protein ladder (5); blank (6); 50 mM 
imidazole (7), 50 mM imidazole (8); blank (9); 250 mM imidazole (10); 250 mM 









4.3.2 Size-exclusion Chromatography 
One common feature of tailspike proteins is their quaternary structure which forms trimers. 
Size-exclusion chromatography of TSP2 reveals a single homogenous peak near the void 
volume indicating a multimeric protein, (see Figure 4.3). The calculated weight according 
to the chromatogram is 470 kDa, which is far than greater the calculated trimeric weight of 
TSP2 (297 kDa); due to the poor accuracy of this method, we can only conclude that TSP2 
is not a monomer in solution.  TSP3 triple mutant (E362Q, D383N, and D426N) expressed 
and produced two peaks on the chromatogram. The earliest peak (8 mL) represents higher 
order aggregates and the second peak (12.5 mL) is consistent with a multimeric protein of 
~270 kDa. Again, the exact molecular weight cannot be determined accurately using this 
method, but TSP3 triple mutant is expected to form a trimer since wild-type TSP3 is a 
trimer in solution and the crystal structure with a predicted molecular weight of 205 kDa. 
TSP4-N monomeric weight is calculated to be (~36 kDa including the 6x-His tag).  The 
first peak at (10.5 mL) indicates higher order oligomers.  The second peak in the TSP4-N 
chromatogram, (14.5 mL) represents a smaller oligomer of TSP4-N. The calculated 
molecular weight for the two TSP4-N species is 590 kDa for the first peak, and 66 kDa for 
the second according to the chromatogram. These results indicate that all TSPs examined 
form oligomers; however, due to the low accuracy of this method partly, due to the 
elongated shape of the TSPs, more information cannot be elucidated. In order to obtain a 
more accurate estimation of the oligomeric state, Dr. Chao, in unpublished data, performed 
analytical ultracentrifugation experiments. She determined that TSP2 and TSP3 form 








Figure 4.3 TSP2 Size-exclusion chromatography. 
The peak of purified TSP2 is shown in red.  The actual molecular weight for TSP2 is 99 
kDa for a monomer and 297 kDa for a trimer. Molecular weight standards (black) are as 
follows: (1) Thyroglobulin, 670 kDa (void volume); (2) Gamma globulin, 158 kDa; (3) 







Figure 4.4 TSP3 Triple Mutant size-exclusion chromatography. 
The peak of purified TSP3 triple mutant is shown in red.  The actual molecular weight 
for TSP3 triple mutant is 69 kDa for a monomer, 205 kDa for a trimer. Molecular weight 
standards (black) are as follows: (1) Thyroglobulin, 670 kDa (void volume); (2) Gamma 









Figure 4.5 TSP4-N size-exclusion chromatography. 
The peak of purified TSP4-N is shown in red.  The actual molecular weight for TSP4-N 
is 36 kDa for a monomer, 108 kDa for a trimer, and 216 kDa for a hexamer. Molecular 
weight standards (black) are as follows: (1) Thyroglobulin, 670 kDa (void volume); (2) 
Gamma globulin, 158 kDa; (3) Ovalbumin, 44 kDa; (4) Myoglobin, 17 kDa; (5) Vitamin 
B12, 1.35 kDa. 
 
 
4.3.3 Protein Stability of TSP2 and TSP3  
 
The thermal stability of TSP2 and TSP3 was determined by the Nelson Lab using CD 
Spectroscopy at 218 nm to monitor the loss in β-sheet content as the temperature increases 
from 20°C to 95°C. The melting temperatures (Tm) for TSP2 and TSP3 were determined 
to be 82.8 °C and 61.8 °C, respectively. The single inflection point of the derivative curve 
indicates that both proteins unfolded cooperatively concomitant with the trimer 





reported for other tailspike proteins. TSPs are usually characterized as extremely stable 
proteins, presumably because they are exposed to harsh environmental conditions. 
Published Tm values for other beta helical tailspike proteins have all been over 80 °C 
including;  TSP1 (Tm=80.7 °C), Phages P22 TSP (Tm =88.4 °C) and HK620 TSP (Tm = 80 
°C) 38, 40, 60. 
 
Figure 4.6  Unfolding curve of  TSP2 and TSP3 as a function of temperature 
monitored by CD spectroscopy. 
(A) Tm of TSP2 is 82.8°C which is consistent with the reported Tm values of other TSPs. 
(B) The Tm of TSP3 is 61.8°C, significantly lower than other TSPs. The experimental 
values are indicated by circles and the continuous line corresponds to the theoretical 
curve.  
 
Lithium dodecyl sulfate (LDS) was used to test the stability of the TSP3 trimer further. 
TSP3 maintained its trimeric association when exposed to the anionic detergent, as shown 
in lane 6 of Figure 4.7. The trimer dissociates only when the protein was boiled as shown 
in lane 5. To determine TSP3 resistance to proteolytic degradation, the protein was 
incubated with trypsin and chymotrypsin for one day, and the corresponding SDS-PAGE 





of TSP3 incubated with trypsin and chymotrypsin respectively; the TSP3 band corresponds 
to a monomer similar to the band shown in lane 5 which was not treated with protease.  
Lanes 8 and 10, which correspond to the un-boiled samples, show an additional band ~50 
kDa lower than the molecular weight of the TSP3 trimer, but still higher than the molecular 
weight of a monomer. In contrast to TSP1, which did not exhibit any proteolytic 
degradation, TSP3 was partially degraded as indicated by band below the full-length trimer.  
  
Figure 4.7 TSP3’s Resistance to Proteolysis 
TSP3 undergoes limited proteolysis by trypsin and chymotrypsin upon 24 hr. incubation. 
Lanes: protein molecular weight ladder (1); Bovine serum albumin (BSA) control (2); 
BSA +trypsin (3); BSA+chymotrypsin (4); TSP3, boiled (5); TSP3, not boiled (6); 
TSP3+trypsin, boiled (7); TSP3+trypsin, not boiled (8); (9-10) same as (7-8) but TSP3 
incubated with chymotrypsin. 
 
N-terminal sequencing of the protein extracted from the lower molecular weight bands 
from the non-boiled samples treated with trypsin and chymotrypsin (Figure 4.7 lanes 8 and 
10) indicated that the N-termini was intact. When these samples are boiled, only one 
protein band is observed representing the full-length TSP3 monomer. A single cleavage 
per trimer on a loop after the neck but before the β-helix of the D3 subdomain can explain 
the presence of the lower band in the non-boiled protease samples.  Cleavage at the position 





catalytic domain ~ 50kDa.  The structure of TSP3 does show two potential cleavage sites 
at Lysine 176 and Tyrosine 190 on a solvent-exposed linker.   
 
4.3.4 Interactions between TSPs 
 
For unknown reasons, the expression of full-length TSP4 was unsuccessful. However, a 
construct of the N-terminal domain of TSP4 was created to probe the role of TSP4 in 
assembling the tailspike complex. Sequence identity between TSP1 and TSP4 indicates 
that the head and catalytic domains of TSP4 begin after residue 335.  Using G7C’s gp66 
as a model along with HHpred’s structure prediction suggests that residues 82 – 350 
comprise a gp10-like module, we predict that the first 335 amino acids contain two 
structural features: a particle binding domain and an assembly domain(s) that mediates the 
interaction with TSP1, TSP2, and TSP3. This TSP4 construct (amino acids 1-335), now 
called TSP4-N was expressed, purified, and used to determine its ability to bind the 
remaining TSPs of phage CBA120. TSP4-N primarily forms a trimer in solution and a 
small amount of hexamers as measured by size exclusion chromatography. 
 
Pull-down experiments, performed by the Nelson Lab, showed that TSP4-N and TSP1 co-
eluted together at 100 mM imidazole indicating a binding affinity between the two proteins. 
Conversely, TSP4-N and TSP3 pull-down experiments did not show interaction. All the 
TSP3 is found in the TSP3 flow through, and the absorbed TSP4-N elutes alone (Figure 
4.8). Recent analytical ultracentrifugation studies performed by Dr. Chao confirmed the 





binds to the complex only in the presence of TSP4-N and TSP2; explaining the negative 
pulldown result for TSP3.  
 
 
Figure 4.8  Pull-down with His-tagged TSP4-N and partner TSPs. 
SDS-Page of pulldown experiment performed with His-tagged TSP4-N and non-his-
tagged TSP1 or TSP3. 
 SDS-Page analyses of TSP1 pulldown (A). Lanes: (1) protein molecular weight 
markers, (2) TSP4-N lysate flow through, (3) wash, (4) TSP1 lysate flow through, (5) 
Wash, 6-11 elution with increasing imidazole concentration: (6-7) 20 mM, (8) 50 mM, 





 SDS-Page analyses of TSP3 pulldown (B).  Lanes: (1) TSP4-N lysate flow through, (2) 
wash  (3)  TSP3 flow through, (4) Wash, (5-6) 20 mM Imidazole, (7) molecular weight 
markers (8) 100 mM Imidazole, (9) 250 mM Imidazole, (10) 500 mM Imidazole. 
 
4.4 TSP1 Crystal Structure - Overview  
 
Chen et al.38 determined the structure of full-length TSP1. TSP1 assembles into an 
elongated homotrimer  with two distinct domains, the head and the receptor binding 
domains (see Figure 4.9 ). The three monomers display extensive interaction burying 
almost a quarter of the surface area38. TSP1’s head domain includes residues 12-155, which 
can be further divided into two subdomains; D1 (residues 12-96) and D2 (residues 97-154). 
A Zn2+ ligand was identified by anomalous diffraction at the zinc absorption edge. The zinc 
ion interacts with TSP1 by coordinating the His25 imidazole group on each monomer and 
a water molecule in a tetrahedral geometry. His25 is buried close to the C-terminus of an 
α-helical bundle formed by the three monomers. 
 
TSP1 C-terminal domain, the receptor-binding domain, spans residues 166-770.  The 
primary structural motif of this domain is a right-handed three-sided β-helix present in both 
subdomains D3 (residues 166-562) and D4 (residues 624-769).  The D3 subdomain was 
predicted to contain the active site, situated in the groove between two monomers38. The 
proposed active site residues include two carboxylic residues Glu456 and Glu483 about 
2.8 Å apart on the same monomer and Asp313 which resides on an adjacent monomer.  
Asp 313 is ~11 Å and ~10 Å apart from Glu456 and Glu483 respectively, and between the 





the arrangement of the carboxylic residues ~10 Å apart, the inverting mechanism for 
glycosyl hydrolysis could explain TSP1 enzymatic activity, discussed in more detail in 
chapter 5. Also, several aromatic residues surrounding the postulated active site may be 
necessary for stabilizing the sugar ring(s) of the polysaccharide substrate including Tyr411 
and Trp380. The D4 subdomain is unique to the TSP1 structure. It forms a β-helix, which 
has a 30-degree bend relative to the D3 subdomain. The bend creates a solvent assessable 
hole in the center of the trimer not seen in other tailspike structures Figure 4.9.  
 
Figure 4.9 The structure of TSP1.  








4.5 TSP2 Crystal Structure  
 
4.5.1 Crystallization, Data Collection, and Structure Determination  
 
A TSP2 crystal was obtained by the vapor diffusion method at room temperature in sitting 
drops. The reservoir solution contained 0.8 M ammonium sulfate and 0.1 M HEPES, pH 
7.0. Only one single crystal appeared after five weeks (Figure 4.10). Further attempts to 
obtain more crystals yielded small crystals unsuitable for data collection, and the SeMet 
protein did not yield crystals at all. The TSP2 crystal was cryoprotected by adding 3μL of 
the reservoir solution supplemented with 30% glycerol to the drop. The crystals were then 
flash cooled with liquid nitrogen. A data set of a TSP2 crystal was collected at Argonne 
National Laboratory, General Medical Sciences and National Cancer Institute (GM/CA) 
beamline 23-ID_B equipped with a MARmosaic MX-300 detector (Marresearch). The data 
was processed using XDS61 and scaled using Aimless62. The structure was determined by 
molecular replacement using Phenix63 and the structure of the TSP2 receptor binding 
domain as the search model (kindly provided by Dr. Petr Lieman). Completion of the 
polypeptide chain and further modification were performed with Coot64, and the structure 






Figure 4.10 Protein crystal of TSP2.  




4.5.2 Overall Structure of TSP2 
TSP2 crystal structure was determined and refined at 1.9 Å resolution yielding an R-factor 
of 0.168 and Free-R of 0.188 with good geometry. Table 4.1 provides a summary of the 
data collection and refinement quality. Analogous to other tailspike proteins, TSP2 crystal 
structure assembles into a homotrimer. The first 168 residues have no associated electron 
density and therefore are not included in the model. As the crystals were not reproduced, 
it is unknown whether this region was cleaved by an E. coli protease that contaminated the 
sample or whether this region is structurally disordered. The C-terminal 6x-His affinity tag 
is mostly disordered, and only a few histidine residues are seen in the final structure. The 
asymmetric unit contains two homotrimers, providing two independent views of the 





point. The trimer association buries over 22,000 Å2 surface area. Two structural domains 
are clearly distinguished in Figure 4.11. The head domain (residues 168-257), consists of 
three lobes, one from each monomer. The second domain comprises the receptor binding 
domain (258-921).  
 
 
Figure 4.11 Structure of TSP2. 
A cartoon representation of the TSP2’s monomer (left) and trimer (middle). The surface 







Table 4.1 Statistics of data collection and refinement of CBA120 TSP2. 
Data Collection TSP2 
Wavelength (Å) 1.0332 
  
Resolution (Å) a 48.36  - 1.9 (1.968  - 1.9) 
Space group P 21 21 21 
Unit cell dimensions (Å) a=83.0 b=259.0 c=269.7 
No. of unique molecule in the asymmetric 
unit 
6 
No of unique reflections a 430672 (45098) 
Multiplicity a 5.0 (5.0) 
Completeness (%)a 99.74 (99.98) 
Mean I/σ(I)a 9.58 (1.41) 
Rmergea 0.126(1.711) 
Refinement  
Resolution (Å) a 48.36  - 1.9 (1.949  - 1.9) 
Total No. of Reflections 430672 (31614) 
Rwork/Rfree 0.168 (0.319)/ 0.188 (0.316) 
No of Protein Residues 4533 
Ligands 117 
solvent 3887 
RMSD from ideal geometry  




Molprobity overall score & percentile 1.90/76th 
aThe values in parentheses are for the highest resolution shell. 
bRmerge = ΣhklΣj|Ij(hkl) – <I(hkl)>| / Σhkl ΣjIj(hkl). 
Rwork = Σhkl | Fo – Fc | / Σhkl Fo, where Fo and Fc are the observed and calculated structure factors, 
respectively. 
Rfree is computed from 4.94% of randomly selected reflections (8672) and omitted from the refinement. 
cCorrelation coefficient between Ec and Eo in SHELXD67. 
dMolprobity geometry score and percentile correspond to PDB structures within the refinement 
resolution range68. 
 
4.5.3 D1 Head Domain 
Consistent with the amino acid homology, the head domain of TSP2, referred to here as 
the D1 domain, has the same fold as the D1 subdomain of TSP1 (and as described later, 
the D1 of TSP3’s head) with an RMSD of 2.2 Å for α-carbon atoms in the D1 domain. 
TSP2’s D1 begins with an helix; the helices of the three monomers interact to form 





of the helix bundle. Proceeding the helix, TSP2’s D1 domain forms an anti-parallel 
sandwich similar to the of the D1 domains of TSP1, TSP3, and gp63.1. However, TSP2 
lacks the D2 subdomain of the homologous TSP head domains. Instead, another -helical 
bundle (residues 248- 257,Figure 4.12) follows the Dl domain. Common to many 
tailspikes, the helix bundle connects the head domain to the receptor binding domain 
and has an appearance of the “neck” of the trimeric structure. 
 
Figure 4.12 TSP2 Head + neck regions.  
A cartoon representation of the head domain and neck trimer of TSP2 (left), rainbow 
representation of the head domain traced in rainbow colored from blue at the N-
terminus to red at the C-terminus (middle). An alignment of D1 of TSP1 (cyan), TSP2 
(magenta), and TSP3 (green) exhibiting the same fold.  
 
 
4.5.4 Receptor Binding Domain 
The receptor binding domain of TSP2 consists of three subdomains, unlike many other 
tailspikes counterparts, which only have two receptor binding subdomains. By analogy to 
other helical TSPs, this domain is presumed to possess glycolytic enzymatic activity. In 
contrast to TSP1 (and as described later also TSP3), whose receptor binding domain 
comprises two subdomains (D3 and D4), TSP2 receptor binding domain can be divided 





twisted around a short helix. Only 57 amino acids, the first subdomain, thereby called 
D3`, is not seen in other helical tailspikes and the function of this domain is not yet 
known (Figure 4.13B). The second subdomain is the D3 subdomain, analogous to other 
TSPs. D3 of TSP2 is 349 amino acids long, comprising a right-handed helix, and the 
three monomer wrap around one another to form a left-handed coiled coil. The C-terminal 
subdomain corresponding to D4 of other TSPs extends out from the main “body” of the 
receptor binding domain to form a propeller-like shape, see Figure 4.13. 
 
 Ensuing the neck, the additional subdomain, herein termed D3` (residues 271-328), adopts 
a “hotdog” fold (an -helix that packs against a -sheet) precedes the -helix D3 
subdomain that carries the glycosides catalytic function. D3’ consists of a one and a half 
turn -helix tucked into a twisted four stranded anti-parallel -sheet. Tailspikes Sf6, 
HK620, and CBA120’s TSP3 do not have such a subdomain; instead, they make an 
irregular extended loop in this position. Dali69 structural comparison of the D3` revealed 
only a weak structural homolog with the highest z score of 2.6 for a protein kinase. The D3 
subdomain (residues 329-678) begins with an -helix cap followed by the -helix. D3 
consists of a three-sided right handed -helix. The three -sheets, labeled herein β1, β2, 
and β3, are intervened by turns of varying length to a total of 10 rungs.  Finally, the D4 
subdomain includes residues 679-921 and adopts a twisted antiparallel -sandwich fold of 
complex topology.  Dali structural comparison revealed 43 structurally similar protein 
domains with a Z score of 10 or greater. Despite a lack of significant amino acid identity, 





GH43 extracellular arabinanase (PDB entry 5HO2, Z score = 13.9, RMSD = 3.2 over 181 
C equivalent atoms) SAP-like Pentraxin (PDB entry 3FLP, Z score = 12.9, RMSD of 
3.5Å over 176 C equivalent atoms) (Figure 4.13 C). Interestingly, an -helix close to the 
C-terminus of D4 caps the C-terminus of D3. In contrast to the N-terminal helical cap of 
D3, helical capping of the C-terminus of D3 has not been seen in other tailspike proteins. 
It remains unknown whether the D4 subdomain is involved in LPS binding even though its 
fold is shared with many carbohydrate-binding proteins.  
 
Figure 4.13 Receptor Binding Domain of TSP2 
(A) Cartoon representation of the monomer highlighting D3` in blue, D3 catalytic 
subdomain in green, and D4 in cyan. (B) Two views of the D3` subdomain, which 
adopts a hotdog fold. (C) Cartoon representation of the D4 subdomain (cyan) 
superimposed on SAP-Like Pentraxin (gray, PDB:3FLP). 
 
  
4.5.5 Putative Active Site for TSP2  
Receptor binding proteins such as TSP2 possess an active site where the LPS antigen can 





two monomers. The potential active site residues include three carboxylic acid residues; 
Asp506 on one molecule and Glu568, Asp571 on the adjacent molecule. Glu568 and 
Asp571 are 6Å apart and on the same monomer, while Asp506 resides on the adjacent 
monomer and measures 3.4Å away from Glu568 and 6.1Å form Asp571. Glu568 is buried 
deep within the binding cavity and is unlikely to be involved in substrate cleavage.  The 
putative active site contains various aromatic F483, W539, and Y623 which may be 
important in sugar stacking. In addition, charged residues such as  R458, E426, and K536, 
and hydrophobic residue L455 are also found in binding pockets to stabilize the 
carbohydrates of the O-antigen70, 71.   
 
 
Figure 4.14 Proposed TSP2 active site. 
(A) A cartoon representation of TSP2’s putative active site situated on the groove 
between two monomers contains putative catalytic residues, D506 and D571. The active 
site also contains various aromatic residues (F483, W539, and Y623), charged residues 
(R458, E426, and K536), and a hydrophobic residue (L455). (B) A surface representation 
of TSP2’s putative active site with important residues. 
 
The presumed mechanism of glycosyl hydrolysis involves two carboxylate residues 





residues to be ~5.5 Å apart while the inverting mechanism requires a larger distance of 
~10Å72, 73 (see Figure 5.1 or section 5.1 for more detail on inverting and retaining 
mechanisms). Both of the potential active site combinations Glu568/Asp571 and 
Asp506/Asp571 are approximately 6Å apart, suggesting the retaining mechanism. The 
structure of TSP2ΔN co-crystalized with O157 antigen (PDB ID: 5W6S) revealed that the 
O157 antigen is bound above residues Asp506 and Asp571 so that the carboxylate residues 
are positioned on either side. The binding of the O-antigen above the potential carboxylate 
residues supports that this location on the trimer is important in TSP2 activity and TSP2’s 
affinity for the O157 antigen.  The binding pocket also contains aromatic, hydrophobic, 
and charged residues such as  Q426, F483, W539, K536, Q571, and Y623 which help 






Figure 4.15 TSP2ΔN with O157 O-antigen tetrasaccharide. 
(A) A cartoon representation of TSP2ΔN with the O157 antigen, indicated by the black 
box, bound in the groove between two monomers. (B) An enlarged image of TSP2ΔN 
(cartoon) with important binding pocket residues (Q426, F483, W539, D506, K536, 
D571, Q571, and Y623) and O157 antigen. Figure adapted from Plattner et al. 
(unpublished work)74. (PDB ID: 5W6S). 
 
4.6  TSP3 Crystal Structure 
 
4.6.1 Crystallization, Data Collection, and Structure Determination  
Crystals of native and SeMet containing TSP3 were obtained by the vapor diffusion method 
in sitting drops at room temperature. The reservoir solution for both native and SeMet TSP3 
crystals contained 18% w/v polyethylene glycol 8000, 0.2M NaCl, and 0.1M CHES, pH 
9.0-9.8. Rod-shaped crystal appeared within a few days (Figure 4.16). The crystals were 
cryoprotected by adding to the drop 3 μL reservoir solution supplemented with 30% 
glycerol. Crystals were flash-cooled in liquid nitrogen. X-ray diffraction data were 
collected at Argonne National Laboratory, General Medical Sciences and National Cancer 





(Marresearch). SAD data for a SeMet TSP3 crystal was acquired at the Se absorption edge 
(0.98 Å) and extended to a resolution of 1.85 Å. The data was processed using 
IMOSFLM75. The phases were determined by the Single Anomalous Diffraction method 
(SAD) using the HKL3000 software, which incorporates the programs SHELXD and 
SHELXE for heavy atom search67, 76, 77. The quality of the electron density map enabled 
most of the polypeptide chains to be built automatically using Autobuild78. Structure 
refinement was performed with the Phenix Refine in the Phenix software suite63, 79.  
 
Figure 4.16 TSP3 Protein Crystal. 
Long rod-shaped protein crystals were formed after a few days.  
 
4.6.2 Overall Crystal Structure  
TSP3 polypeptide consists of 627 amino acids with an additional six histidine residues at 
the C-terminus engineered to facilitate protein affinity purification. The protein forms a 
biological homotrimer and the asymmetric unit (Figure 4.17). The first 13-14 amino acids 





trimer is approximately 165 Å in length and 65 Å in diameter across the widest area and 
contains two domains, with the C-terminal domain making up roughly 75% of the overall 
structure. 
 
The globular head domain, which is believed to mediate TSP attachment, is composed of 
2 subdomains per chain, termed D1 and D2 (residues 13-96 and 97-154, respectively). An 
ensuing three α-helix bundle (residues 155-168) form the “neck” of the trimer. Next, the 
receptor binding domain is divided into the larger D3 subdomain (169-574) and a smaller 
D4 subdomain (598-627), which are connected by a 23 amino acid linker. The D3 
subdomain forms a right-handed β-helix comprising 13 complete turns. Similar to TSP1, 
the interface between pairs of monomers in this region contains a negatively charged 
pocket that might bind and cleave the LPS substrate.  






Figure 4.17 Structure of TSP3. 
A cartoon representation of the monomer (left), the trimer (middle), and surface 








Table 4.2 Statistics of data collection, phasing, and refinement of CBA120 TSP3. 
Data Collection Wild-type Se-Met 
(absorption edge 
peak) 
Wavelength (Å) .97932 .97939 
Resolution (Å) a 54.2-1.85 (1.92-1.85) 29.6-1.91 (1.94-1.91) 
Space group P 21 P 21 
Unit cell dimensions (Å) 
a=99.4, b=66.8, c=161.6, 
β=103.6 
a=67.7, b=117.6, c=121.0, 
β=100.8 
No. of unique molecule in 
the asymmetric unit 
3 3 
No of unique reflections a 175806 (17301) 140860 (6814) 
Multiplicity a 2.0 (1.9) 2.6 (2.6) 
Completeness (%)a 99.7 (99.1) 98.1 (95.8) 
Mean I/σ(I)a 12.5 (4.8) 12.2 (1.6) 
Rmergea 0.048 (0.217) 0.058(0.687) 
SAD-Phasing   
Resolution (Å)   2.1 
No. of Se atoms 
(found/correct)  
 29/19 
CC (%)c  37.1 
Refinement   
Resolution (Å) a 1.85 (1.871 – 1.850)  
Total No. of Reflections 175535 (5468)  
Rwork/Rfree 0.152 (0.206)/0.184 (0.233)  
No of Protein Residues 1851  
Ligands 95  
solvent 1829  
RMSD from ideal geometry   







Molprobity overall score & 
percentile 
1.4, 98%  
aThe values in parentheses are for the highest resolution shell. 
bRmerge = ΣhklΣj|Ij(hkl) – <I(hkl)>| / Σhkl ΣjIj(hkl). 
Rwork = Σhkl | Fo – Fc | / Σhkl Fo, where Fo and Fc are the observed and calculated structure factors, 
respectively. 
Rfree is computed from 4.94% of randomly selected reflections (8672) and omitted from the refinement. 
cCorrelation coefficient between Ec and Eo in SHELXD67. 







4.6.3  Head Domain  
The head domain of TSP3 shares 71% sequence identity with that of TSP1. Both head 
domains adopt the same overall fold with an 0.5 Å RMSD of α-carbon atoms (see Figure 
4.18). The head domain region of several Cba120virus genus members demonstrates 
sequence identity: Salmonella phage Det7 TSP (97% identity), Escherichia phage PhaxI 
(80% identity), and Salmonella phage PhiSH19 (97 % identity) indicating a conserved head 
structure. There are examples of TSP’s with homology to TSP3’s head domain in both 
subfamilies of the Ackermannviridae family, the Aglimvirinae (Dickeya phage 
LIMEstone1 - 73% identity) and the Cvivirinae (Salmonella Phage ViI - 94% identity).  
Lastly, E. coli phage G7C’s TSP gp63.1 possess 70% identity to CBA120’s TSP3, despite 
belonging to the Podoviridae family and demonstrating an entirely different receptor 
binding structure that deacylates the LPS41. The shared head domain of TSP1 and TSP3 is 
found not only in multiple genera but also in multiple families suggesting that these 
proteins may have a common ancestor.    
 
There are only a few examples of the TSP head domains structures in the Protein Data 
Bank because they are often truncated to facilitate crystallization. TSP3’s head domain 
shares the same fold as CBA120’s TSP1 and G7C’s gp63.1. Although the TSP3 head 
domain residues 13-154 have higher temperature factors than those of the receptor binding 
domain, nevertheless the associated electron density map is well defined. The D1 
subdomain begins with an α-helix where Asn24 is coordinated to an Mg2+ ion at the trimer 





chains and three water molecules, as shown in Figure 4.18. The cation coordination at the 
center of the trimer may contribute to the stability of the head domain. 
 
Figure 4.18 The head domain of TSP3 
 (A) A rainbow cartoon representation of the two subdomains. (B) Top view of TSP3 
trimer showing the octahedral Mg2+ coordination (yellow) to 3 Asn24 side-chains, 
one from each monomer, and three water molecules (red). The cation binds at the base 
of the N-terminal 3-helix bundle. (C) Stick representation of Mg2+ (yellow) 
coordination with an Mg-ligand distance range of 2.1-2.2 Å. 
 
4.6.4 Receptor-Binding Domain 
The receptor binding domain begins with a helical neck linker which is followed by two 
splayed loops.  The 61 amino acid residues (residues 169-230) which form the loops 
contain 1-turn, 2-turns, and 3-turns α-helices, which wrap below the neck. The loop 
containing the first two α-helices interdigitates between the neck’s α-helix and the receptor-
binding domain of a neighboring monomer to enhance protein-protein interactions. The 2-
turn α-helices of the trimer (Val193- Asp199) form a 3-helix bundle along the axis of the 
neck with translational displacement and tilt relative to the neck helices. The loop 
containing the 3-turn α-helix caps the ensuing β-helix domain, traversing the center of the 





have been observed in other tailspikes, including CBA120 TSP138 and the SF680 and 
HK620 tailspikes60. The α-helix capping of the β-helix also occurs in pectate lyase60, 80, 81.  
 
The three-sided β-helix, beginning at residue 231, is comprised of three repeating β-strands 
units, B1, B2, and B3 separated by three turns T1, T2, and T3. The length of the turns 
varies; with T3 facing the trimer interface being the shortest (1-3 residues) and several of 
the T1 and T2 containing extended loops. Notably, two large loops (residues 402-415 on 
T3 and residues 522-533 on T2) interact with one another across monomer, see Figure 4.19 
Figure 4.13. The interface between two monomers defines a crevice along the two 
neighboring β-helices, and the intermolecular interaction mediated by the above two loops 
towards the C-termini of the β-helices block the crevice. As discussed in the next section 
and the following chapter, the active site residues are located close to this edge. This 
suggests an endoglycosidase binding/cleaving activity for TSP3. 
 
As seen with other β-helical molecules, the core of each β-helix is stabilized by 
hydrophobic and aromatic residues including Phe294, Tyr318, Phe338, and Phe366. Other 
hydrophobic residues are also involving (Ile386, Ile420, Ile443).  Within the hydrophobic 
core, three cysteines (Cys341, Cys369, Cys389) are positioned sequentially along three 
rungs of the internal β-sheet ladder, yet no disulfide bond is observed, possibly because the 
geometry is not appropriate. Strikingly, one positively charged residue in the center of each 
β-helix, Arg343, lacks an accompanying negatively charged residue. Instead, the charge is 





molecule.  Intermolecular interactions along the trimer axis are mediated by both 
hydrophilic and hydrophobic interactions with many internal water molecules that solvate 
the hydrophilic residues.   Notably, three His367 side chains stack edge to face along the 
longitudinal axis of the trimer. An exquisite salt bridge network exists along the rungs N-
terminal to the His367 cluster includes: Arg340, Asp319, Arg320, Asp296, Arg295, and 
glu254. Asp317 and Glu254 on the neighboring monomer are also involved, thus 
supporting the trimer assembly, see Figure 4.20. In addition, A PO4 
-3 ion coordinates three 
Arg295 and three Arg233 at the N-terminal end of the β-helix. Multiple water molecules 
surround the charged network (see Figure 4.19). Another striking structural feature below 
the histidine cluster is the stacking of 4 threonine residues (Thr387, Thr421, Thr444, 
Thr470) on sequential rungs of the internal β-sheet ladder, each on the C-terminus of a β-







Figure 4.19 The receptor binding domain of TSP3. 
The receptor binding domain of TSP3 monomer with the linker region highlighted in red, 
resulting in the displacement of D4 relative to D3 (left). In the D3 domain of TSP3 there 
is a phosphate ion with positively charged residues at the trimer symmetry axis including 
direct interactions with Arg233, Arg295, and interaction with Lys231 via a bridging water 








Figure 4.20 Intermolecular interactions along TSP3's 3-fold axis. 
Intramolecular charge-charge interaction along the 3-fold axis of TSP3 catalytic 
domain (A). The side chains of His367 stack edge to face followed by the stacking of 
threonine residues along the β-helix rungs (B). 
 
 
4.6.5 Proposed TSP3 Active Site  
Similar to TSP2, the proposed active site of TSP3 resides in the groove between two 
monomers in the receptor binding domain, see Figure 4.21. There are three carboxylic acid 
residues present in the active site cleft; Glu362 and Asp383 on one monomer, and Asp426 
on the adjacent monomer. All three of these residues are located 6.1 to 6.9 Å apart. In 
addition to the proposed catalytic residues, several aromatic residues decorate the active 
site including Phe322, Tyr324, Trp344, Tyr335, Phe370, and Phe392. Aromatic residues 
are known to stack against sugar pyranose rings, which may assist with orienting the LPS 
substrate. Site-directed mutagenesis (discussed in chapter 5) revealed that Glu362 and 
Asp426 are the two carboxyl residues involved in TSP3’s enzymatic activity consistent 






Figure 4.21 Proposed TSP3 active site. 
(A) A cartoon representation of TSP3’s putative active site situated on the groove 
between two monomers, potential catalytic residues include E362, D383, and D426. The 
putative active site contains aromatic residue Y335 and polar residue H334. (B) A 
surface representation of TSP3’s putative active site with important residues. 
 
4.7  Crystallization and Diffraction Data Collection of TSP4 
Full-length TSP4 was not expressed; however, the N-terminal domain comprising residues 
1-335, herewith termed TSP4-N, was overexpressed and purified in sufficient quantities to 
begin structural studies. Diffracting crystals of TSP4-N were obtained by myself and by 
Dr. Chao using the vapor diffusion method in sitting drops at room temperature (Figure 
4.22). TSP4-N crystals were obtained in 0.1 M Bis-Tris pH 6.0, 1.6 M ammonium sulfate, 
0.1 M TCEP hydrochloride after a few days. Data was first collected at the Institute for 
Bioscience and Biotechnology Research home source using Rigaku MicroMax007 X-ray 
generators and RAXIS IV++ detector; however, the crystal diffracted poorly. Dr. Chao also 
obtained crystals of TSP4-N with the following crystallization conditions 1 M potassium 





LiSO4, 0.1 M NaCl, and 0.1 M Hepes 7.5; in both cases, crystals appear after a few weeks. 
For heavy atom derivatives crystals were soaked in crystalizing solution supplemented with 
40 mM solution JBS Magic Triangle I3C 82, after which the crystals were back soaked in 
crystallizing solution supplemented with 30% glycerol and then flash cooled in liquid 
nitrogen.  Diffraction data was collected GM/CA Beamline 23-IDB at Agronne National 
Laboratory. The data extended to ~3 Å resolution and processed with XDS61. 
Unfortunately, the crystals did not exhibit a strong anomalous signal, and the structure 
could not be determined by SAD method. Currently, work is underway to determine the  
TSP4-N  structure by molecular replacement methods using models derived from the 
unpublished structure of phage G7C’s gp66 provided by Dr. Lieman using the  Modeller 






Figure 4.22 Crystals and Diffraction Images of TSP4-N.  
Protein crystals and diffraction images of TSP4-N (A, D) 0.1M Bis-Tris pH 6.0, 1.6 
M ammonium sulfate, 0.1 M TCEP hydrochloride (B, E) 1.6 M LiSO4, 0.1 M NaCl, 
and 0.1 M Hepes 7.5 (C, F) 1 M K+ Na+-tartrate, 0.2 M NaCl, and 0.1 M imidazole-
HCl pH 8.0.  
 
  
4.8 Structural comparison of CBA120 TSPs  
The head and receptor binding domains of tailspikes 1-4 all have a similar elongated 
morphology of ~150 Å in length, with a “head”, “neck”, and “body” (the crystal structure 
TSP4 lacking the N-terminal 340 amino acid residues was recently deposited by Petr 
Leiman group in the PDB, entry code 5W6H).  The smaller TSP1 and TSP3 structures are 
more similar to one another because their C-terminal D4 domain is small and they contain 
only two receptor binding subdomains. In contrast, the C-terminal D4 subdomains of TSP2 





contain three subdomains (D3’, D3, and D4). In addition, TSP2 and TSP4 contain N-
terminal regions that mediate the assembly of the branched structure attached to the 
baseplate of phage CBA120, whose structures are not yet available. Nevertheless, all four 
phage CBA120 TSPs share a common shape with glycosidase tailspike proteins from other 
bacteriophages, and they form homotrimers containing a catalytic domain that adopt the 
right-handed -helix fold.  
 
4.8.1 Head domains 
There are only a few tailspike protein crystal structures that include the head domains, 
perhaps because some full-length molecules have inherent flexibility that impedes 
crystallization. Thus, the TSPs structures from phage CBA120 enriches the set of known 
head domain architectures substantially. When first published, the fold of TSP1 head 
domain was novel (TSP1 PDB ID: 4OJ5). The fold did not resemble that of the head 
domain of phage P22 TSP, the only other available head domain structure at the time.  
Subsequently, the TSP  head domain of tailspike gp63.1 from phage G7C revealed the 
same fold as that of TSP1 even though the catalytic domain has an entirely different 
structure and catalytic activity41. Consistent with their sequence homology, the structures 
of TSP2, TSP3, and TSP4 head domains share the same fold except that the D2 subdomain 
of TSP2 is missing. The first 10-15 residues of TSP1 and TSP3 are disordered in the crystal 
structure. This is consistent with the Psipred Protein sequence analysis58, 59 that predicts 
these areas to be disordered and perhaps involved in protein binding. For TSP2, the entire 
170 residue N-terminal region, which is likely to mediate the assembly with other phage 





Moreover, the structure of the N-terminal 335 amino acid residues of TSP4, which 
probably mediates both the attachment to the phage baseplate and assembling the partner 
TSPs is still unknown. Beyond these flexible regions, the head structure of TSP4ΔN begins 
with an N-terminal head three α-helix bundle, which is largely buried within the head 
domain and is followed by the three α-helix bundle neck seen in all TSPs with known 
structure.  
 
TSP1 and TSP3 both have heads that adopt the same fold (Figure 4.23) with two 
subdomains and share a Cα atom positions RMSD of 0.48 Å. The head domain for TSP1 
and TSP3 is approximately 42 Å long and 55Å across.  Similarly, TSP4 shares the same 
fold as that of TSP1 and TSP3 consistent with the 70% sequence identity of these regions. 
TSP4 exhibits RMSD of .53 Å and 0.54 Å with TSP1 and TSP3 for the α-carbon atoms of 
the head domain. In contrast, TSP2’s head domain contains only the D1 subdomain (39% 
and 29% sequence identity with the D1 domains of TSP1 and TSP3), is considerably 
shorter at 35 Å and a Cα atom positions RMSD of 1.2 Å with the D1 subdomain of TSP1 
that indicates some structural divergence (Figure 4.23). The missing D2 subdomain 
suggests that D1 and D2 evolved independently as folding units and perhaps that the D2 
subdomain is not essential for interaction with partner proteins.     
 
The head domain of phage G7C gp63.1 adopts the same fold as TSP1, TSP3, and TSP4, 
and has a Cα atom positions RMSD value of 0.5Å to TSP141 head even though the G7C 





than the TSPs of phage CBA120. From an evolutionary perspective, this raises the 
possibility of horizontal transfer of genetic material consisting of DNA that encodes 
independent folding units. Finally, the head domain of phage P22 TSP adopts an entirely 
different fold comprising two -sheets85, and accordingly, it shares no sequence homology 
with the amino acid sequences of phages CBA120 and G7C TSPs. 
 
Figure 4.23 Head domains of phage CBA120 and phage P22 TSPs. 
A rainbow cartoon representation of the TSP 1-3 and P22’s tailspike. The polypeptide 
chain is colored progressively from blue at the N-terminus to red at the C-terminus. The 
red helices form the trimeric necks of all the structures. TSP1, TSP3, and TSP4 have two 
subdomains, and TSP2 has only one subdomain. P22 TSP (PDB:2VNL) contains a single 
all- subdomain.  
 
 
4.8.2 Receptor binding domain  
The receptor binding domains of phage CBA120 TSPs follow the α-helical bundle 
comprising the “neck.” For the TSP of phage P22, the neck was thought to allow flexibility 
between the head domain and receptor binding domain85. The postulated flexibility was 
hypothesized to facilitate the ability of multiple tailspikes to contact the target O-antigen, 





contact with O-antigen receptors for infectivity86.  Thus, the necks of CBA120 TSPs may 
also play a similar role. 
Ensuing the neck but preceding the -helix is a conserved capping motif that stacks above 
the -helix. Such a cap, reminiscent of that reported in pectate lyase81, is commonly seen 
in -helices. Prokhorov and colleagues suggested that the region between the head domain 
and the receptor binding domain may be a junction site for horizontal gene transfer, 
explaining cases of non -helical receptor binding domains that possess a similar motif41. 
As mentioned above, the catalytic domain of gp63.1 adopts a different fold (SGNH-
esterase), yet it contains a -helix cap41. Indeed, the structures of TSP2 and TSP4 contain 
the D3’ subdomain inserted within this junction site, further supporting this proposed 
hotspot for horizontal transfer. The D3’subdomain, observed so far only in TSP2 and TSP4, 
adopts in both proteins the hotdog fold, with a 0.5 Å RMSD over Cα positions of the 
subdomain and 33 % sequence identity. 
  
A striking characteristic of the glycosidase-class of TSPs including, TSP1-4 of phage 
CBA120 and the TSPs of phages Sf6, P22 and HK62 is that despite their common -helical 
fold of the D3 catalytic domain, they lack significant sequence homology. Moreover, the 
number of rungs along 3-faced -helix domains varies from protein to protein. 
Accordingly, these domains do not align well with one another. Yet, they contain common 
features: the triangular cross-section of the -helix is concave along the exterior edge of 
the triangle and flat along the edges that are involved in subunit-subunit interactions. In 





are located on the interior vertex of the triangles. These tight loops tend to have the same 
conformation along the rungs of the -helix ladder yielding a regular packing of the trimer 
subunits and a triangular internal channel.   
 
So far, the D4 subdomain exhibit the highest variability among -helical TSPs, as most 
TSPs adapt different D4 folds. With phage CBA120, TSP1’s D4 subdomain forms a right-
handed 3-stranded –helix. That of TSP2 forms a -sandwich of complex topology similar 
to the carbohydrate binding protein pentraxin. D4 of TSP3 forms a 3-stranded -sheet that 
the trimer assembles into a -prism II, a fold associated with carbohydrate binding.  
Moreover, the D4 subdomain of TSP4 (determined by the Leiman’s group) folds into a -
sandwich similar to a carbohydrate domain 61. Thus, all phage CBA120 D4 domains could 
potentially be involved in carbohydrate binding of the appropriate substrate or other 
carbohydrates on the bacterial surface. Interestingly, TSP3 has the shortest D4 subdomain 
(29 amino acids). The structure is broadly similar to the last 30 residues of the D4 
subdomain of phage P22 TSP; however, D4 of phage P22 TSP is much larger. P22 TSP 
also forms a beta prism motif that has been proven important for trimer stabilization87, 88. 
It is tempting to speculate that the small TSP3 D4 subdomain contributes to the relatively 
low thermal stability of TSP3. 
 
4.8.3 Structure-based putative locations of the catalytic sites  
Vacuum surface electrostatic potentials of these trimers were calculated using PyMol to 





qualitative, a consistent trend emerges for all four TSPs showing a prominent negatively 
charged patch in grooves corresponding to interfaces between trimer subunits. These 
patches contain carboxylate groups that may function as the glycosidase catalytic 
machinery as discussed earlier. The location of the TSP3 catalytic site has now been 
confirmed by site-directed mutagenesis, as discussed in Chapter 5. TSP1 and TSP2 
catalytic sites are currently being tested in the lab by site-directed mutagenesis as well. 
The TSP1 negative electrostatic potential is formed by Glu456 and Glu483 on one 
molecule and Asp313 on the adjacent molecule, as discussed earlier in this chapter. The 
negative patch on TSP2 surface is formed by Asp506 on one molecule and Glu568, 
Asp571 on the adjacent molecule, an arrangement that is also discussed in the previous 
section. TSP3 has a negatively charged pocket involving the carboxylate groups of 
Glu362 and Asp383 on the same monomer and Asp426 of the neighboring monomer. 
Finally, based on the coordinates deposited in the PDB (entry code 5W6H), the 
negatively electrostatic potential corresponding to TSP4 active site candidate includes 
Glu675 on one monomer and Asp737 on the neighboring monomer, which are located 
10 Å apart and are surrounded by two tyrosine, and tryptophan, residues that are often 
encountered within catalytic sites of glycosidase. Table 4.3 summarizes the distances 
between catalytic residues candidates of phage CBA120 TSPs, which shows that both 
the short (~6 Å) and the long distances (~10 Å) between carboxylate groups 
corresponding to retaining and inverting stereochemistry acid/base hydrolytic 
mechanism, respectively, may be employed by the TSPs of phage CBA12073. Once all 
TSPs catalytic residues are identified, it will be possible to assess the diversity of the 





Table 4.3 Proposed active sites of TSP1-3. 
 Proposed Active Site 
Residues  
Distance apart (Å) Suggested 
Mechanism  
TSP1 E456/D313 11.2 Inverting  
E483/D313 10.2 Inverting 
TSP2 D506/D571 6.1 Retaining  
TSP3 E362/D426 6.7 Retaining 
TSP4* E675/D737 10 Inverting 
* PDB ID: 5W6H 
 
 
Figure 4.24 Vacuum surface electrostatic potential of TSP1-3. 
Calculated using PyMol, positively charged region are colored blue and negatively 
charged regions are colored red. Boxes indicate the location of the proposed active 







Chapter 5: Tailspike activity 
 
5.1   Introduction 
 
For bacteriophages to replicate, they must be able to infect their host bacteria and 
commandeer its machinery to create new progeny. During the infection process, receptor 
binding protein engages the receptors present on the bacteria before adsorption can occur. 
Many species of bacteria have developed extensive LPS and Extracellular polymeric 
substances (EPS) that surround the bacteria and provide a physical barrier obstructing the 
bacteriophage’s access to the host cell surface. In response, bacteriophages have evolved 
specialized proteins that allow them to degrade these carbohydrate barriers and infect their 
host bacteria. One group of proteins that enable phages to traverse these obstacles are 
depolymerases (reviewed by Hughes et al. 13, 21). 
The two main classes of phage depolymerases known to target extracellular bacterial 
carbohydrate structures are lyases and hydrolases1. Lyases cleave glycosidic bonds by the 
elimination mechanism and can be subdivided into several classes based on their target 
molecule including hyaluronidases, alginate lyases, and pectin/pectate lyases1. Hydrolases, 
catalyze the breaking of chemical bond using water molecules, hydrolases can also be 
divided into several subclasses including sialidases, levanases, xylosidases, dextranases, 
rhamnosidases, peptidases, etc1. So far many annotated tailspike proteins have been 
identified as hydrolases; including those from bacteriophages P22, HK620, Sf6, Phi29, 
K1F, and G7C.  
Some hydrolases degrade the O-antigen, for example, phage P22’s tailspike has 





hydrolases may modify the O-antigen without cleaving the polysaccharide backbone, for 
example, phage G7C’s tailspike gp63.1 has esterase activity towards an acetyl substituent 
of the O-antigen. Furthermore, phage  φ29’s tailspike is a teichoicase that degrades the 
poly (glycerol phosphate) teichoic acid that makes up part of the Gram-positive bacteria 
Bacillus subtilis cell wall90. In this chapter, I describe investigations to determine the 
activities of TSP1-3.  
 
Glycosyl hydrolases have two primary mechanisms to catalyze the hydrolysis of a 
glycosidic bond, as first described by Koshland in 195373. The retaining mechanism is a 
two-step reaction, catalyzed by two carboxylate-containing residues, where one residue 
acts like an acid (proton donor) and the other as a base (nucleophile). Each step inverts the 
stereochemical configuration at the sugar’s anomeric carbon; thus a double inversion 
results in the final product retaining its original stereochemistry. First, the base attacks the 
anomeric center, creating a glycosyl-enzyme intermediate and releasing the terminal sugar, 
which has been protonated by acid. In the second step, the deprotonated carboxylate group 
deprotonates a water molecule which mounts a nucleophile attack to hydrolyze the 
glycosyl-enzyme intermediate (Figure 5.1). This mechanism requires approximately 5.5 Å 
between the two catalytic residues because the hydrolytic water molecule replaces the 
leaving saccharide fragment.  
 
The second glycosidase mechanism inverts the stereochemical configuration of the 





residues are two carboxylate residues, one acts as an acid and the other as a base. This is a 
concerted reaction, with the base deprotonating the nucleophilic water that attacks the 
anomeric center. Concurrently, the leaving group deprotonates the acid (Figure 5.1B). The 
inverting mechanism requires a larger distance between the catalytic residues of ~10 Å 
because the hydrolytic water molecule binds between the base and the saccharide substrate.  
 
Figure 5.1 Mechanism of glycosyl hydrolases. 
(A) The retaining mechanism involves a two-step reaction. (B) The inverting mechanism 






5.2 Materials and Methods 
 
5.2.1 Bacterial strains  
 Bacterial strains that were purchased from the American Type Culture Collection (ATCC) 
include toxigenic (EC43894) and non-toxigenic (EC700728) strains of E. coli O157:H7, 
and negative control non-O157:H7 E. coli strains (EC35218) that produces O6 O-antigen. 
E. coli O157:H7 (EDL933) was obtained from Matthew Waldor’s laboratory where it was 
genetically modified to create three gal mutants, TEA023, TEA026, and TEA028, which 
are deficient in O157 antigen91. Deletion-insertion mutations to genes responsible for 
modifying galactose to N-acetyl-D-galactose, a component in O157 antigen, were 
introduced in these knockout strains. E. coli O157 mutant TEA023(ΔgalU::aad-7) replaced 
all but the first 33 bp and the last 30bp of the galU gene open reading frame with the 
spectinomycin gene (aad-7)91. For the ΔgalETKM mutant TEA026(ΔgalETKM::aad-7), all 
the genes in the gal ETKM operon where replaced with the spectinomycin gene, except the 
first 36bp and the last 30bp of the galE and galM genes, respectively. 
TEA028(ΔgalETKM::tetA), is similar to TEA026(ΔgalETKM::aad-7) but it contains the 
tetracycline resistance gene (tetA) instead of the spectinomycin gene91. 
 
5.2.2 Plaque assay   
Host cultures were prepared by growing an overnight culture of strains EC35218, 
EC700728, TEA023, TEA026, and TEA028 in sterile LB media at 37 ºC and 220 rpm. The 
inoculation culture was prepared by making a 1:100 dilution of the overnight culture in 
fresh LB media and incubating at 37 ºC and 220 rpm until the culture reached OD600 of 
0.30. Petri dishes were prepared by dissolving 7.5 g of agarose into 500 mL of sterile LB 





solidify. Top agar was prepared by dissolving  2.5 g of agarose in 500 mL sterile LB Media 
and kept at 55 ºC in a hot water bath to prevent the agar from solidifying.  0.05 mL of 5 x 
104 CFU/mL of phage was used to inoculate 250 µL of the host culture and incubated for 
10 min at 37 °C. The inoculated culture was then transferred to 3 mL of molten top agar 
and poured onto a prepared petri dish. After the top agar layer has solidified, the plates 
were transferred to 37 ºC incubator overnight and observed the next day. The formation of 
discrete clear spots in the bacterial lawn indicated the presence of bacteriophage capable 
of infecting and lysing the bacteria in that location. 
  
5.2.3  Adsorption assay  
E. coli 700728 culture was grown at 37 ºC to OD600 of 0.1. 500 µL EC700728 was mixed 
with ~100 µg tailspike protein or BSA or 23 µg inactive PlyC (negative controls) and 500 
µL of 5x10 4 CFU/mL phage CBA120 in SM buffer (100 mM NaCl, 8 mM MgSO4, and 
50 mM Tris-HCl). The mixture was incubated for 8 min at 37 °C and then centrifuged for 
1 min at 14,000 g. The supernatant was removed and used in a serial dilution and added to 
250 µL of 9x107 CFU/mL E. coli 700728. 3 mL molten top agar was added to the mixture 
and poured onto a plate. After the agar solidified, the dish was transferred to a  37 ºC 
incubator overnight. This procedure was adapted from Prokhorov et al. 201741.   
5.2.4  Turbidity assay 
E. coli 700728 culture was grown at 37 ºC to OD600 of 0.2. 250 µL was mixed with 100 
µg/mL, 50 µg/mL, 25 µg/mL, or 5 µg/mL of tailspike protein in SM buffer. The mixture 
was incubated for 30 min at 37 ºC. 125 uL of 5x10 4 CFU/mL phage CBA120 in SM buffer 
was added to the mix of the E. coli and tailspike protein. Control conditions included E. 





tailspike protein, and tailspike protein without the CBA120 phage. 150uL of the final 
mixture was transferred into the 96 well plates in triplicate. The plates were incubated at 
37 ºC, and the OD600 was measured every 30 min for 8 h. A summary of all the conditioned 
used is provided in Table 5.1. 
Table 5.1 Conditions of E. coli 0157:H7/ phage CBA120 turbidity assay. 
 
Condition  E.coli Phage  Tailspike protein (µg/mg)  
E.coli control + - - 
Phage control + + - 
TSP1control  + - 50 
TSP1 + + 5,25,50, 100 
TSP2 control + - 50 
TSP2  + + 5,25,50, 100 
TSP3 control + - 24 
TSP3  + + 5,10,15, 24 
TSP1 and TSP2 control + - 50 
TSP1 and TSP2 + + 5,25,50, 100 
 
5.2.5 Halo assay  
Halo assays were performed by the Nelson Lab. A 50 mL culture E. coli O157:H7 (ATCC 
700728) was grown overnight at 37 °C to an OD600 = 1.6. The cells were centrifuged at 
4,150 rpm, and at 4 °C for 10 min and the supernatant was removed. The cell pellet was 
washed three times with 1x PBS buffer and resuspended in 1 mL PBS. 500 µL of the 
washed cells were mixed with 10 mL 0.7% agarose solution and poured into a 100 mm 
plate. After solidifying, 0.5 cm wells were made using sterile plastic dropper tips. Initially, 
10 µL of 6 mg/mL TSP 1-3 in PBS was added to the wells, and for TSP3 mutants halo 
assay 45 µg protein wild-type TSP3 and TSP3 mutants were added to the wells. The plates 
were incubated at 37 °C for up to 48 h. This protocol was adapted from K. A. Hughes et 





and photographed.  
5.3   Results   
5.3.1  TEA mutants and phage CBA120 
The LPS of E. coli O157:H7 contains a modified galactose residue as one-fourth of a 
repeating polysaccharide motif of the O-antigen. Without the gal operon GalE, GalT, GalK, 
and GalU proteins,  E.coli EDL933 is unable to synthesize N-acetyl-D- galactose of the 
O157 antigen91.  Because of the exposed LPS core E. coli O157:H7 gal mutants are 70% 
more susceptible to P1 transduction phage than the wild-type E. coli O157:H791.  
 
A plaque forming assay was used to investigate the phage CBA120 ability to infect the 
wild-type E. coli O157:H7 and the O157 gal mutants. When phage CBA120 is inoculated 
with E. coli O157:H7 (ATCC 700728) that produces intact O-antigen, phage plaques form 
- confirming reports that CBA120 infects E. coli O157: H727, 91. Non-O157:H7 E. coli 
(ATCC 35218) has a different O-antigen  O692, and no plaque formation was seen after 
inoculation with phage CBA120, as expected from its specificity (Table 5.2). It is believed 
that interactions between the O-antigen and phage tailspike proteins are essential to the 
adsorption process and without the correct TSP O-antigen receptor,  phage CBA120 
tailspikes are unable to degrade the LPS and reach the primary receptor on the cell 
surface21. The idenity of CBA120’s primary receptor is not known: however in phage 
infection irreversable binding to a primary receptor on the cell surface is essentail to the 
infection process22. It is also important to note that E. coli strain 35218 may not possess 
the necessary primary receptor to facilitate infection. Nonetheless, phage CBA120 ability 
to infect E. coli strain 700728 but not strain 35218 is consistent with the previous study of 






To probe the importance of the O157 O-antigen to phage CBA120 infection, O157 gal 
mutants (TEA 023, TEA 026 and TEA 028) were inoculated with the phage. None of the 
gal mutants showed plaque formation, confirming that the O157:H7 O-antigen is required 
for phage CBA120 infection (Table 5.2). Previously, studies of phage P22 adsorption 
demonstrated that phage P22’s TSP must interact with several S.typhimurium O-antigen 
chains for phage adsorption to proceed86. The authors hypothesized that phage P22 must 
interact with three O-antigen chains and orient itself appropriately with respect to the 
primary receptor for infectivity 86. It is tempting to speculate that a similar process occurs 
when phage CBA120 infects E. coli O157:H7.  
 
 
Table 5.2 Phage CBA120 plaque formation on E. coli O157:H7 gal mutants. 
E. coli strain 35218 700728 TEA023 TEA026 TEA028 
Plaque 
formation  
- + - - - 
- no plaque, + plaque   
 
 
 5.3.2 Adsorption inhibition Assay  
The phage adsorption assay tests how many phages are adsorbed onto the bacterial surface 
during an 8-minute incubation. By adding exogenous TSPs to the phage titer, their effect 
on phage CBA120’s ability to infect E. coli O157:H7 (ATCC 700728) can be assessed.  If 
a TSP is involved in phage attachment, it would compete with the phage for the receptors 
on the bacteria and inhibit phage ability to bind to the bacteria, resulting in higher free 
phage titer in the supernatant compared with a reference assay performed without TSP. 





subsequent plaque formation. Table 5.3 summarizes the combination of components used 
in these experiments.  
 
Phage titer and the subsequent plaque formation is limited by the number of phages that 
can traverse the LPS and infect the bacteria. Negative control proteins, BSA and inactive 
PlyC, in the presence of bacteria and phage have no significant effect on phage CBA120 
adsorption and should yield the same phage titer as the reference mixture of phage and 
bacteria. Indeed, they produced a lower phage titer than the control comprising phage alone 
without bacteria. TSPs 1-3 do not form any plaques without the addition of phage CBA120, 
which confirms that it is the phage CBA120 that creates the plaques and not the TSPs alone. 
Of the three TSPs tested, plaque formation following the addition of TSP1 was similar to 
that of the BSA and inactive PlyC negative controls. Lower plaque formation indicates that 
TSP1 is not competing with the phage CBA120 receptors as it does not lower free phage 
titer by preventing adsorption. 
 
Unexpectedly, both TSP2 and TSP3 increased plaque number dramatically, and thus 
infection efficiency, when compared to the reference of maximum phage titer in the 
absence of bacteria (Figure 5.2). Higher phage titers can be explained by the enzymatic 
activity of TSP2 and TSP3 which increases phage access to the primary receptors of E. coli 
O157:H7 and thus enhances phage CBA120’s infectivity. Such activity must not prevent 
phage binding to the bacterial cells and could include non-specific cleavage of surface 





saccharide backbone. Nonetheless, the adsorption inhibition confirmed TSP2 and TSP3 
activities, although it did not reveal a TSP1 activity.  
 
Table 5.3 Conditions of E. coli O157:H7/CBA120 Adsorption Inhibition Assay 
Proteins  EC 700728 Phage  Protein amount (ug) 
None (free phage control) - + - 
BSA (Control) + + 100 
Inactive PlyC (Control) + + 23 
TSP1 + + 100 
TSP2 + + 100 




Figure 5.2 Phage CBA120 adsorption inhibition assay. 
The histogram bars are as follows: The control free phage titer (first); phage titers in the presence 
of BSA and inactive PlyC after incubation with E. coli O157:H7 (2 and 3). Phage titers in the 
presence of TSP1-3 in (4-6). 
 
5.3.2 Turbidity assay 
Phage CBA120 replication has been documented by Kutter et. Al27 in 2011. Under 
anaerobic conditions, the gradual bacterial lysis began after 90 minutes. In an attempt to 





















concentrations of TSPs and phage were incubated together at 37 °C and growth was 
monitored at 600 nm. Controls included E. coli O157:H7 cells without phage or TSP to 
monitor normal anaerobic growth, E. coli cells and phage without TSP as the reference 
phage lysis level. Moreover, cultures include TSPs and E. coli 700728 without phage to 
confirm that TSPs alone does not affect cell growth and not plaques were formed (data not 
included). 
 
TSP1 and TSP3 showed no effect on phage CBA120’s ability to infect E. coli O157:H7. 
The cell density of E. coli O157:H7 increased over the first 100 minutes for all conditions 
after which differences were apparent. The control cells without phage CBA120, either 
with the E. coli O157:H7 alone or in the presence of a TSP displayed logarithmic growth 
until they reached a plateau after 500 minutes. In the presence of phage CBA120, bacterial 
growth reached a maximum between 100 and 200 minutes and then the cell density 
declined sharply as phage CBA120 lysed them.  The presence of varying amounts of TSP1 
















Figure 5.3 turbidity assay of E. coli O157:H7 and TSP1. 
Turbidity assay displaying the growth of E. coli O157:H7 as a function of time 
(minutes). the TSPl_control contains 50mg/mL TSP1without CBA120 phage, 
TSPl_100 contains 100mg/mL TSP1with phage CBA120, TSPl_50 contains 
50mg/mL TSP1 with phage CBA120, TSPl_25 contains 25mg/mL TSP1with phage 
CBA120, TSPl_5 contains 5mg/mL TSP1with phage CBA120, and Cells Control 
contains only E. coli.  
 
 
Figure 5.4 Turbidity assay  of E. coli O157:H7 and TSP3. 
Turbidity assay displaying the growth of E. coli O157:H7 as a function of time 
(minutes). the TSP3_control contains 24mg/mL TSP3 without CBA120 phage, 
TSP3_24 contains 24mg/mL TSP3 with phage CBA120, TSP3_15 contains 15mg/mL 
TSP3 with phage CBA120, TSP3_10 contains 10mg/mL TSP3 with phage CBA120, 
TSP3_5 contains 5mg/mL TSP3with phage CBA120, and Cells Control contains only 






























































In contrast to TSP1 and TSP3, which did not affect bacterial cell infection by phage 
CBA120 TSP2 exhibited concentration dependent inhibition of phage infectivity. The 
highest concentration of TSP2, 100 ug/mL of abolished phage CBA120 infectivity, and 
this culture growth curve is similar to the cells controls with and without TSP2 but 
lacking the phage. Decreasing the amount of exogenous TSP2 increased the cell 
infection by phage CBA120 resulting in decreased E. coli growth. These results support 
the conclusion that TSP2 competes with the phage for the secondary E. coli O17:H7 
receptor and in the highest concentration completely prevents phage attachment to the 
LPS. Turbidity assays with the gal mutants, TEA023, TEA026, and TEA028, which 
lack the O-antigen, revealed that phage CBA120 was unable to infect and lyse E. coli 
O157:H7 (data not shown). By analogy, we hypothesize that the phage had no access 
to the bacterial LPS receptor in the presence of TSP2 either because TSP2 occupied all 






Figure 5.5 Turbidity assay of E. coli O157:H7 and TSP2. 
Turbidity assay displaying the growth of E. coli O157:H7 as a function of time 
(minutes). the TSP2_control contains 50mg/mL TSP2 without phage CBA120, 
TSP2_100 contains 100mg/mL TSP2 with phage CBA120, TSP2_50 contains 
50mg/mL TSP2 with phage CBA120, TSP2_25 contains 25mg/mL TSP2 with phage 
CBA120, TSP2_5 contains 5mg/mL TSP1with phage CBA120, and Cells Control 
contains only E. coli. 
  
 
5.3.3  Halo assay and Identification of TSP3 Catalytic Residues 
Although tailspikes do not lyse bacterial cells, the thinning of the LPS layer can be viewed 
as a halo of less density or less opacity on an agar dish embedded with sensitive bacteria. 
Whereas this does not address the specific glycosidic cleavage site, it does allow for semi-
quantitative demonstration and comparison of activity. 
   
Purified TSP1-3 applied to E. coli O157: H7 embedded in agarose caused the formation of 
halos extending from the well site. The halos indicate that E. coli Ol57:H7 O-antigen or 

































showed the smaller less clear halo. Both TSP2 and TSP3 formed more evident halos, by 
comparison, consistent with a more active depolymerase activity. While these findings are 
indicative of TSP enzymatic activity, they do not divulge information about catalytic rates 
or substrate specificity. While the 3D structures of these TSPs suggest that all have 
glycosidase activity, it is possible to form halos by degrading non-specific polysaccharides, 
particularly in the case of the low activity of TSP1. This possibility was tested further by 
expanding the halo assay to examine other bacterial strains and species. It was found that 
the TSPs form halos on both E. coli O157:H7 strains tested (ATCC 7000728 and ATCC 
43894). In contrast, none of the TSPs formed halos when applied to either a non-O157:H7 
strain of E. coli (ATCC 35218) or other Gram-negative bacterial species (K. pneumoniae, 
P. aeruginosa, A. baumannii). Although the data initially suggested that TSP1-3 display 
specificity for the O157:H7 O-antigen, these TSPs were also capable of inducing halos 
when using the E. coli mutants TEA023 (knockout of the galU gene) and TEA026 
(knockout of the galETKM operon), which lack the O157 O-antigen. Taken together, TSP1 
and TSP3 glycosidase activity does not appear to require the presence of the O157 antigen. 
Whether they act on the outer core or inner core moieties of LPS or other bacterial surface 






Figure 5.6 Halo formation by phage CBA120 TSPs 1-3. 
TSP halo formation on E. coli O157:H7 agar plates. PBS negative control shows no halo. TSP1 
forms the least distinct halo while TSP2 and TSP3 form similar size halos. 
 
 
The ability of the TSPs to induce halos provides an assay to probe residues proposed to 
comprise the catalytic machinery by site-directed mutagenesis. This has been determined 
for TSP3, and now studies of the TSP2 and TSP1 catalytic residues are in progress.  
 
Using the halo assay, equal weighted amounts of purified wild-type and mutant TSP3 
proteins were analyzed (Figure 5.7,Table 5.4) in order to determine which amino acid 
residues comprise the catalytic machinery. As expected, a halo was observed when spotting 
wild-type TSP3 (Figure 5.7, well 1), while the buffer only negative control (Figure 5.7, 
well 9) was devoid of activity. Similar to the negative control, the TSP3 
E362Q:D383N:D426N triple mutant (Figure 5.7, well 8) was incapable of generating a 
halo, implying glycosidase activity was abolished and thus confirming the location of the 
active site. Individual TSP3 point mutants were assayed next in order to identify which 
specific residues are required for catalysis. When compared to wild-type, the TSP3 D383N 
mutant (Figure 5.7, well 3) displayed comparable activity, indicating D383 is dispensable 





mutants exhibited activity defects. Contrary to E362Q:D383N (Figure 5.7, well 5) and 
D383N:D426N (Figure 5.7, well 7), the activity of the TSP3 E362Q:D426N double mutant 
(Figure 5.7, well 6) was abolished. This result suggests the two essential catalytic residues 




Table 5.4 TSP3 active site mutant halo assay results. 
Well  Mutation   Halo Formation  
1 N/A ++ 
2 E362Q + 
3 D383N ++ 
4 D426N + 
5 E362Q and D383N + 
6 E362Q and D426N - 
7 D383N and D426N + 
8 E362Q, D383N, and D426N - 
9 PBS control - 
Well numbering corresponds to Figure 5.7 






Figure 5.7 TSP3 wild-type and TSP3 active site mutants halo assays. 
E. coli strain ATCC 700728 was embedded in agarose. Wells (3 mm) were cut out of the agarose 
and loaded with 10 µL (6 mg/mL) wild-type TSP3 or active site mutants and incubated overnight 
to visualize tailspike activity. (A) (1) wild-type TSP3; (2) TSP3 E362Q; (3) TSP D383N; (4) 
TSP3 D426N; (5) TSP3 E362Q:D383N double mutant; (6) TSP3 E362Q:D426N double mutant; 
(7) TSP3 D383N:D426N double mutant; (8) TSP3 E362Q:D383N: D426N triple mutant; (9) 
PBS control. (B) Identical image to (A) with a dashed white line to indicate the halo edge to aid 
in visualization. Quantitation of Figure 5.7 is shown in Table 5.4. 
 
 
5.3.4  Conclusions  
Several conclusions may be derived from the activity studies. First, with the employed 
methods, TSP1 has the least observable activity compared with the other tailspikes. 
Nevertheless, the halo assay confirms that O157:H7 LPS or another polysaccharide is a 
substrate for the enzyme even though the halo it induces is not as pronounced as the halos 
from the other TSPs. The turbidity assay and the phage adsorption assay indicate that 
within the time range of these experiments (minutes), TSP1 lacks enzymatic activity 
toward the phages receptor. However, the halo assay enables the ongoing site-directed 






Of the three TSPs, only TSP2 exhibits receptor binding activity, as it was able to inhibit 
phage CBA120 infection of E. coli O157:H7. Thus, it appears the TSP2 is the glycosidase 
that degrades the E. coli O157:H7 LPS. Once the catalytic residues are determined by site-
directed mutagenesis, the TSP2 mutants could also be evaluated by the turbidity assay to 
determine whether the elimination of the enzyme activity also eliminates TSP2’s ability to 
inhibit Phage CBA120 infection.    
 
TSP3’s enzymatic activity appears to be similar to that of TSP2 in several aspects. Both 
TSP2 and TSP3 have more robust halo producing activity than TSP1. Similarly, to TSP2, 
TSP3 also increases the efficacy of phage adsorption, which may be caused not only 
competing with the phage for binding to the secondary receptor during the 8 min incubation 
period but also by enzymatic activity that these TSPs have towards E. coli O157:H7’s LPS 
or other polysaccharide during the day period required for plaque formation. However, in 
contrast to TSP2, TSP3 does not inhibit phage CBA120 infection, and therefore its 
substrate is probably not the O-antigen. The halo assay with TSP3 mutants confirm that 
Glu362 and Asp426 comprise that catalytic machinery even though the TSP3 substrate 






Chapter 6: Conclusions and Future Prospects  
 
Phage CBA120 specially infects the food pathogen E. coli O157:H727. Exploring the 
interactions between phage CBA120 and E. coli O157:H7 could lead to discovering new 
biocontrol agents to fight or monitor E. coli O157:H7 infections. Through a collaboration 
between the Herzberg and Nelson Labs, we have been able to reach several conclusions 
about the structure and function of phage CBA120’s tailspike proteins. Electron 
microscopy images of phage CBA120 showed its unusual tail structure. Bioinformatics 
studies and sequence analysis allows us to predict structural domains and their function. 
Finally, the structure determination of TSP1-3 has revealed putative active sites and 
catalytic residues. The catalytic residues of TSP3 were confirmed by site-directed 
mutagenesis, and those of TSP1 and TSP2 are currently being investigated.  
 
To better understand CBA120’s tailspike proteins in phage infectivity both functional and 
structural studies will continue to be pursued. Determining the structures of the N-terminal 
domains of TSP2 and TSP4 will provide valuable insight into the assembly of the tailspike 
complex. Analytical ultracentrifugation experiments will continue to probe the interaction 
between the TSPs.  Future studies will also focus on determining the substrates of TSP1, 
TSP3, and TSP4 through biochemical assays. Ultimately these studies will not only provide 
insight into the infectivity mechanism of phage CBA120 but they will also serve as a 


















TSP2 gp163 orf211 YP_004957865.1 
TSP3 gp164 orf212 YP_004957866.1 





























































































































































































Appendix 2: Primers 
 
Appendix Table  1 Primers for TSP3 Site-Directed Mutagenesis 







































Appendix Table  2 Primers for TSP4 Constructs 
TSP4 
Construct 
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